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Abstract
5-Aminolevulinate synthase (ALAS) catalyzes the pyridoxal 5’-phosphate (PLP)dependent condensation between glycine and succinyl-CoA to generate coenzyme A (CoA),
CO2, and 5-aminolevulinate (ALA). The chemical mechanism of this reaction, which represents
the first and regulated step of heme biosynthesis in mammals, involves the formation of a shortlived glycine quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using
liquid chromatography coupled with tandem mass spectrometry to analyze the products from the
reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we
directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate
intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow
absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate
upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate,
the external aldimine predominates over the glycine quinonoid intermediate. When instead of
glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the
L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was
not detected in the T148A-catalyzed L-serine external aldimine formation. These results with
T148A, a mALAS2 variant, which, in contrast to the wild-type enzyme, is active with L-serine,
suggest that the active site T148 modulates the strict amino acid substrate specificity of ALAS.
The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed as a lag

x

in the ALA external aldimine formation progress curve), consistent with conformational changes
governing the dissociation of ALA from ALAS.
In Rhodobacter capsulatus ALAS, apart from coordinating the positioning of succinylCoA, N85 has an important role in regulating the opening of an active site channel. Here, we
have mutated the analogous asparagine of murine erythroid ALAS to a histidine (N150H) and
assessed its effects on catalysis through steady-state and pre-steady-state kinetic studies.
Quinonoid intermediate formation occurred with a significantly reduced rate for the N150Hcatalyzed condensation of glycine with succinyl-CoA during a single turnover. When the same
forward reaction was examined under multiple turnovers, the progress curve of the N150H
reaction displayed a prolonged decay of the quinonoid intermediate into the steady-state, distinct
from the steep decay in the wild-type ALAS reaction. This prolonged decay results from an
accelerated transformation of the product, ALA, into the quinonoid intermediate during the
reverse N150H-catalyzed reaction. In fact, while wild-type ALAS catalyzes the conversion of
ALA into the quinonoid intermediate at a rate 6.3-fold lower than the formation of the same
quinonoid intermediate from glycine and succinyl-CoA, the rate for the N150H-catalyzed reverse
reaction is 1.7-fold higher than that of the forward reaction. We conclude that N150 is important
in establishing a catalytic balance between the forward and reverse reactions, by favoring ALA
synthesis over its non-productive transformation into the quinonoid intermediate. Mutations at
this position could perturb the delicate heme biosynthetic equilibrium.
Circular dichroism (CD) and fluorescence spectroscopies were used to examine the
effects of pH (1.0-3.0 and 7.5-10.5) and temperature (20 and 37 °C) on the structural integrity of
ALAS. The secondary structure, as deduced from far-UV CD, is mostly resilient to pH and
temperature changes. Partial unfolding was observed at pH 2.0, but further decreasing pH

xi

resulted in acid-induced refolding of the secondary structure to nearly native levels. The tertiary
structure rigidity, monitored by near-UV CD, is lost under acidic and specific alkaline conditions
(pH 10.5 and pH 9.5/37 °C), where ALAS populates a molten globule state. As the enzyme
becomes less structured with increased alkalinity, the chiral environment of the internal aldimine
is also modified, with a shift from a 420 nm to 330 nm dichroic band. Under acidic conditions,
the PLP cofactor dissociates from ALAS. Reaction with 8-anilino-1-naphtalenesulfonic acid
corroborates increased exposure of hydrophobic clusters in the alkaline and acidic molten
globules, although the reaction is more pronounced with the latter. Furthermore, quenching the
intrinsic fluorescence of ALAS with acrylamide at pH 1.0 and 9.5 yielded subtly different
dynamic quenching constants. The alkaline molten globule state of ALAS is catalytically active
(pH 9.5/37 °C), although the kcat value is significantly decreased. Finally, the binding of 5aminolevulinate restricts conformational fluctuations in the alkaline molten globule. Overall, our
findings prove how the structural plasticity of ALAS contributes to reaching a functional
enzyme.
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Chapter One
Introduction
The importance of heme for the existence of all living organisms is paramount. This
tetrapyrrolic compound, which consists of iron bound to protoporphyrin IX, serves as a
prosthetic group for a number of proteins involved in the transport and storage of divalent gasses,
redox reactions, and electron transport (1, 2). Even though in all organisms the first committed
step of heme biosynthesis represents the formation of 5-aminolevulinate (ALA), the precursors
used for its synthesis differ (2). In plants, archaea, and most bacteria, ALA is synthesized in a
two-enzymatic step reaction from glutamyl-tRNA (2). This pathway, known as the C5-pathway,
entails the initial reduction of glutamyl-tRNA into glutamate-1-semialdehyde by the enzyme
glutamyl-tRNA reductase (2). Then, glutamate-1-semialdehyde-2,1-aminomutase converts
glutamate-1-semialdehyde into ALA (2). In contrast, heme biosynthesis in non-plant eukaryotes
and some bacteria proceeds via the C4-pathway (also known as the Shemin pathway), in which
ALA is formed from the enzymatic condensation of glycine and succinyl-CoA by the pyridoxal
5’-phosphate (PLP)-dependent enzyme 5-aminolevulinate synthase (ALAS) (2-4). The central
focus of this dissertation will be ALAS. In this chapter, introduction to the seminal discoveries
related to the mechanism, structure, and regulation of the enzyme is provided that will serve to
guide the reader into subsequent chapters where original experimental work is presented.

1

Historical perspective1
Discovery of ALAS and its substrates and products
During the mid-1940s, significant effort was invested toward identification of the initial
precursors of heme, with most work being conducted in the laboratories of David Shemin and
Albert Neuberger. In fact, it was David Shemin who initially demonstrated in 1945 that all four
nitrogen atoms of the tetrapyrrolic ring of heme are derived from the amino group of glycine (5).
He came to this conclusion after ingesting 66 g of 32% 15[N] glycine in addition to his usual diet,
and observing that the isotopic nitrogen atoms are being incorporated in heme molecules isolated
from his own blood (5). Once glycine was discovered as the initial precursor of heme, it was
further demonstrated that only the alpha carbons of glycine are incorporated into the heme
molecule (6), indicating that 24 out of the 32 carbons of heme must be derived from a molecule
other than glycine. This led to the suggestion of a four-carbon asymmetric TCA cycle
intermediate as a potential precursor of heme, resulting in the proposal and subsequent
corroboration of succinyl-CoA as being that precursor (7).
With the identification of glycine and succinyl-CoA as the initial substrates of heme
biosynthesis, it was postulated that condensation between the two substrates at the α-carbon of
glycine would result in the formation of α-amino-β-ketoadipic acid (8, 9). Decarboxylation of the
α-amino-β-ketoadipic acid at the original α-carbon of glycine will then result in the formation of
5-aminolevulinic acid (ALA), and it was proposed that ALA could potentially serve as the
source for all nitrogen and carbon atoms of the heme molecule (8, 9). Synthesized chemically in
1

Note to reader. Portions of this section (i.e., Historical Perspective) were published as a book chapter in The
Handbook of Porphyrin Science (4) [Fratz, E. J., Stojanovski, B.M., and Ferreira G.C (2013) Toward Heme: 5Aminolevulinate Synthase and Initiation of Porphyrin Biosyntehsis. The Handbook of Porphyrin Science (Ferreira,
G.C., Kadish, K.M., Smith, K.M., and Guilard, R. Eds) World Scientific Publishing Co., Singapore. pp 1-78]. B. M.
Stojanovski contributed equally in writing this book chapter and the section used in this dissertation was written by
him.
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the laboratories of Shemin and Neuberger, it was demonstrated that ALA is capable of inducing
heme synthesis (8, 9). Briefly, it was shown that heme synthesized in avian erythrocytes from
ALA labeled with either

15

N or

14

C contained significantly higher concentration of the isotopic

label in comparison to heme that was synthesized from glycine labeled with either 15N or 14C (9).
It was also demonstrated that the addition of unlabeled ALA significantly reduced the isotopic
activity of heme that was synthesized in the presence of either 14C glycine or 14C succinate (9).
The results strongly suggested that ALA is indeed an intermediate in the heme biosynthetic
pathway that is formed upon the condensation of glycine and succinyl-CoA.
The identification of ALA as an intermediate in heme biosynthesis was followed by
reports of its enzymatic synthesis (10, 11). In 1958, the group of Neuberger reported the
enzymatic biosynthesis of ALA in freeze-dried particles obtained from avian erythrocytes (10),
and in the same year the group of Shemin reported the enzymatic biosynthesis of ALA in
particle-free extracts obtained from Rhodopseudomonas spheroides and Rhodospirillum rubrum
(11). In all cases, it was clearly demonstrated that the substrates utilized by the enzyme in the
synthesis of ALA were glycine and succinyl-CoA. With the identification of ALAS, along with
its substrates and products, the identity of the enzyme that initiates heme biosynthesis was finally
resolved.

Discovery of the internal aldimine and its tautomeric species
In 1958 the research groups of Shemin and Neuberger independently demonstrated that
PLP is required as an essential cofactor for the reaction catalyzed by ALAS (10, 11). It was
observed that the formation of ALA in bacterial and avian extracts was dependent on the
presence of PLP; omission of the cofactor from the reaction system resulted in decreased

3

formation of ALA, suggesting that PLP is required for catalysis (10, 11). In all PLP-dependent
enzymes, the PLP cofactor is bound covalently through a Schiff base to the ε-amino group of an
active site lysine, forming what is commonly referred to as an internal aldimine (12). In the case
of ALAS, however, certain disparities were noted in opinions regarding the interaction between
the enzyme and cofactor, with some investigators proposing an active site cysteine to be
involved in the interaction with the cofactor (13-15).
In contrast with the research groups that postulated an interaction with a sulfhydryl
group, Nandi (16) proposed and validated that the PLP cofactor was bound to the ε-amino group
of an active site lysine through a Schiff base linkage. In order to examine the possibility that a
lysine was involved in the covalent interaction with the cofactor, Nandi (16) reduced R.
spheroides ALAS with sodium borohydride in the presence of PLP, and examined acidhydrolyzed fractions for the presence of ε-N-pyridoxyllysine. Observation of a single fluorescent
spot on a paper chromatogram whose mobility was identical to the one of chemically synthesized
ε-N-pyridoxyllysine that served as a reference, was suggestive of the presence of ε-Npyridoxyllysine in the acid hydrolytes sample. Therefore, Nandi (16) concluded that the PLPcofactor was bound covalently to the ε-amino group of lysine, resulting in the formation of an
internal aldimine (16). In agreement with these findings, Ferreira et al. (17) identified the exact
lysine residue involved in the formation of the ε-N-pyridoxyllysine in murine erythroid ALAS
(henceforth abbreviated as mALAS2). After reducing recombinant mALAS2 with tritiated
sodium borohydride, the enzyme was digested with trypsin; the generated peptides were
separated using high pressure liquid chromatography, and most of the tritium label was found in
a single fraction. The sequence of the tritium-labeled peptide was determined, establishing that
K313 (murine ALAS2 numbering) was bound to the PLP cofactor through a Schiff base linkage
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(17). Importantly, when K313 was mutated to a glycine, alanine, or histidine, the cofactor no
longer formed a Schiff base linkage with the active site lysine, but rather, it was bound noncovalently to the enzyme, as a free aldehyde (18). The subsequent elucidation of the crystal
structure of Rhodobacter capsulatus ALAS corroborated that the PLP cofactor is indeed bound
to the ε-amino group of an active site lysine (19).
Detailed characterizations of the spectroscopic properties of ALAS have contributed to
the elucidation of the different tautomeric structures assumed by the internal aldimine (Fig. 1.1).
The absorbance spectra of mALAS2 in the absence of substrates revealed the presence of two
absorption bands: one with an absorbance maximum at 330 nm and another with an absorbance
maximum at 410 nm (20). As with other PLP-dependent enzymes, the absorption peak at 410 nm
was assigned to the ketoenamine form of the internal aldimine (Figure 1.1) (20). The absorption
peak at 330 nm was assigned to the substituted aldamine form of the internal aldimine (Figure
1.1), since a fluorescence emission maximum around 385 nm was observed upon excitation of
the enzyme at 330 nm (20). In theory, the 330 nm-absorption species could have been assigned
to an enolimine tautomer; however, if that were the case then excitation of ALAS at 330 nm
would have resulted in a fluorescence emission maximum at ~515 and not at 385 nm (20). The
spectral data strongly suggested that the 330 nm absorption band represented the substituted
aldimine species (20).

Figure 1.1. Tautomeric structures of the internal aldimine. (A) Ketoenamine, Absmax = ~420 nm, (B)
Substituted aldamine, Absmax = ~330 nm, (C) Enolimine, Absmax = ~330 nm.

5

Elucidation of the reaction mechanism
With the identification that the activity of ALAS depends on PLP, Kikuchi et al. (11)
proposed a putative mechanism for the reaction catalyzed by ALAS, based on the assumption
that PLP is required in the activation of glycine. These investigators proposed that in order for
glycine and succinyl-CoA to condense at the α-carbon of glycine, formation of a carbanion
intermediate, resulting from the cleavage of one of the bonds to the α-carbon of glycine, would
be required. Since it was recognized that the carbanion intermediate could be formed either from
decarboxylation or deprotonation of the α-carbon, two different reaction mechanisms were
considered (11). In the first mechanism, the carbanion intermediate was envisioned to result from
decarboxylation of the glycyl carboxyl group. Then, condensation with succinyl-CoA would
produce ALA upon the release of the coenzyme-A moiety. In the second mechanism, the
carbanion intermediate, which would arise from removal of one of the hydrogen atoms bonded to
the glycine α-carbon, would condense with succinyl-CoA to yield an α-amino-β-ketoadipate
intermediate. The subsequent decarboxylation of the α-amino-β-ketoadipate intermediate would
either be spontaneous (i.e. non-enzymatic) upon the release of the intermediate from the enzyme
or occur on the surface of the enzyme, with ALAS acting as a decarboxylase. Numerous studies
followed (discussed briefly on the following pages) that allowed us to distinguish between these
two putative mechanisms, and the refined chemical mechanism is outlined in Scheme 1.1 (see
legend for summary).
The individual steps of the chemical reaction mechanism of ALAS were mainly resolved
with the initiation of a series of radiolabeling experiments. Akhtar and Jordan (21) were the first
to clarify the differences between the two potential mechanisms, demonstrating that the
formation of the initial carbanion intermediate involves the abstraction of one of the α-protons of
glycine. Upon the incubation of enzyme preparations of R. sphaeroides ALAS with 2RS [3H2]
6

glycine and succinyl-CoA it was observed that only half of the tritium label was retained in ALA
(21).

Scheme 1.1: Proposed chemical mechanism for the reaction catalyzed by ALAS. In the resting state,
PLP binds covalently to an active site lysine as an internal aldimine (I) [PLP-K313 internal aldimine in
mALAS2]. The entry of glycine in the active site proceeds with the formation of an external aldimine (II).
Removal of the pro-R proton of glycine results in formation of a first quinonoid intermediate (III), which
facilitates the condensation with succinyl-CoA and subsequent release of the CoA moiety (IV). When the
resulting 2-amino-3-ketoadipate intermediate (V) is decarboxylated (H207-assisted decarboxylation in the
mALAS2 reaction), an enol intermediate is formed (VI) which is in rapid equilibrium with a second
quinonoid intermediate (VII). The final reaction intermediate is the ALA external aldimine (VIII).

7

Retention of one-half of the original tritium label in ALA indicated a reaction involving
deprotonation of the α-carbon, for if the reaction involved initial decarboxylation, then the entire
tritium label would have been retained in ALA. Therefore, the researchers concluded that the
carbanion intermediate is formed as a result of the abstraction of one of the α-protons of glycine
(21). To test whether the abstraction of the proton was catalyzed in a stereospecific manner,
Jordan and Akhtar (22) used serine transhydroxymethylase to generate pro-R and pro-S
enantiomers of glycine. Incubation of these enantiomers with R. sphaeroides ALAS established
that the pro-R proton is abstracted from glycine, and the formation of the carbanion intermediate
is stereospecifically catalyzed (23).
Once it was established that the reaction mechanism entails initial deprotonation of
glycine, it became evident that condensation between the resulting carbanion and succinyl-CoA
would involve formation of an α-amino-β-ketoadipate intermediate. Further, in order for ALA to
be formed from the α-amino-β-ketoadipate intermediate, decarboxylation at the original α-carbon
would have to occur, which in theory can either be spontaneous (i.e., non-enzymatic) or
enzymatic. Evidence in favor of enzymatic decarboxylation of this intermediate emerged from
the finding that upon incubation of ALAS with tritiated pro-S enantiomer of glycine, the tritium
label was found in the S-configuration at the C5 position of ALA (24). If decarboxylation were
to be non-enzymatic then the C-5 position of ALA was going to be racemic. Demonstration of
the reversibility of the ALAS-catalyzed reaction provided further evidence in support of
enzymatic decarboxylation and established that the enzyme can act as decarboxylase (25).
In agreement with a mechanism that entails initial deprotonation of glycine, Hunter and
Ferreira (26) identified K313 of mALAS2 as the amino acid that acts as a base-catalyst during
the abstraction of the pro-R proton from glycine. This is the same amino acid that forms a Schiff

8

base linkage with the PLP cofactor in the absence of substrates (17). It was demonstrated that
while the reaction of wild type mALAS2 with [2-3H2]-glycine resulted in loss of one-half of the
original tritium label within the first hour of the reaction, there was no detectable loss of tritium
label in the reaction of the K313G variant with [2-3H2]-glycine, strongly supporting that K313 is
the catalytic base that removes the pro-R proton of glycine (26).
In many PLP-dependent enzymes, the PLP cofactor functions to stabilize negative charge
development on the C-α of the amino acid substrate, by facilitating delocalization of the
electrons through the  system of the pyridinium ring (12). The resulting carbanions are termed
quinonoid intermediates, displaying absorbance maximum at ~510 nm (12). In fact, the
spectroscopic detection of a quinonoid intermediate was particularly useful in elucidating the
kinetic mechanism of ALAS (27-29). Characterization of the pH dependence of the mALAS2catalyzed formation of the quinonoid intermediate during pre-steady state kinetic analyses
revealed an acid catalyzed process (29). Since radiolabeling studies had demonstrated that K313
facilitates initial deprotonation of glycine by acting as a base catalyst (26), while the quinonoid
intermediate transiently detectable during pre-steady state kinetic analyses was catalyzed in an
acid-dependent manner, Hunter et al. (29) proposed that the spectroscopically detectable
intermediate must be the second quinonoid intermediate which results from decarboxylation of
the α-amino-β-ketoadipate intermediate, rather than the initial quinonoid intermediate formed
upon deprotonation of glycine. Based on structural modeling of the α-amino-β-ketoadipate
intermediate in the active site of ALAS, it was suggested that an active site histidine (H207 in
mALAS2) can act as an acid catalyst by protonating the β-keto carbonyl oxygen the α-amino-βketoadipate, which would facilitate decarboxylation and subsequent formation of the quinonoid
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intermediate that is predicted to be in a rapid equilibrium with an enol (29). The refined
mechanism is summarized in Scheme 1.1.

The Crystal structure of R. capsulatus ALAS
The crystal structure of R. capsulatus ALAS reveals a homodimeric enzyme whose
individual monomers consist of three separate domains (Fig. 1.2) (19). As with other fold type I
PLP-dependent enzymes, the enzymatic active site is located at the dimeric interface, and is
composed of amino acids from the individual monomers. In the active site of the holoenzyme,
PLP is bound covalently to the ε-amino group of K248 (R. capsulatus ALAS numbering)
through a Schiff base linkage (Fig. 1.3A) (19). The pyridinium ring of the resulting internal
aldimine is positioned between H142 and V216, with each amino acid stacking the ring from an
opposite side. Interactions with H217 and D214 are not only important for proper positioning of
PLP, but also for enhancing the electron sink function of the cofactor during catalysis (30, 31).
The phosphate group further stabilizes the positioning of PLP by forming six different hydrogen
bonds with active site amino acids from each monomer (19).
The binding of glycine in the active site results in the formation of an external aldimine
with PLP (Fig. 1.3B) (19). Non-covalent interactions with S189, N54, and R374 (R. capsulatus
ALAS) stabilize the positioning of glycine within the active site, and the salt bridge with R374 is
particularly important in attaining a catalytically favorable orientation, as evident from the
abolished activity that ensued when the analogous arginine was mutated to a leucine in mALAS2
(32). Upon binding to ALAS, succinyl-CoA establishes interactions with all three domains of the
individual monomer as well as interactions with the catalytic domain of the opposite monomer
(Fig. 1.3C) (19). The adenosyl group binds in a hydrophobic pocket located on the surface of the
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enzyme. Within this pocket, the ribose moiety of succinyl-CoA forms a hydrogen bond with
K156, whereas the adenine group forms hydrogen bonds with S137, D138, and S139, ensuring
specificity between the substrate and the enzyme. The adenine group is further stabilized by two
hydrophobic amino acids, I146 and I158, positioned on either side of the ring. In contrast to the
adenosyl moiety, the succinate group binds deep in the active site, where one of its carboxyl
oxygen interacts with R21, T365, and N85, whereas the other oxygen forms a hydrogen bond
with T83. The surface of the enzyme is connected to the active site pocket through an active site
channel, which, in the succinyl-CoA-bound structure, is occupied by its pantetheine moiety.

Figure 1.2. Crystal structure of homodimeric R. capsulatus ALAS. The N-terminal domain is shown
in red, the catalytic domain in purple, and the C-terminal domain in cyan. The other subunit is in gray.
PLP is shown as yellow sticks. PDB code: 2BWN.
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Figure 1.3. The active site of R. capsulatus ALAS. (A) PLP bound covalently to the active site lysine as
an internal aldimine, (B) glycine bound covalently to PLP as an external aldimine, (C) succinyl-CoA
bound to the active site of ALAS.
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Conformational changes and the reaction rate-limiting step
Two distinctive conformations, open and closed, were observed in the crystal structure of
R. capsulatus ALAS (Fig. 1.4) (19). During the transition between the open and closed
conformations, segmental rearrangements result in the repositioning of a loop over the active site
(residues 358-375 in R. capsulatus ALAS) that narrows the active site pocket of ALAS, and the
mobility of this flexible loop is partly restricted by the binding of succinyl-CoA through
interactions with the succinyl-pantetheine moiety. Further rearrangements during the
conformational transitions entail the repositioning of a C-terminal helix and a short linker
(residues 332-348 in R. capsulatus ALAS) toward the N-terminus. The fact that in all substratebound structures ALAS assumes the closed conformation implicates that this conformation is the
catalytically competent one. Interestingly, even though the structural rearrangements that induce
conversion of ALAS to the closed conformation minimize the exposure of the active site to the
solvent, the active site becomes fully protected from the solvent only upon the binding of
succinyl-CoA.

Figure 1.4. The crystal structure of R. capsulatus ALAS in the open (blue) and closed conformations
(magenta). The active site loop which closes and opens over the active site is shown in the insert.
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Detection of a pre-steady-state burst of ALA formation during quenched-flow kinetic
analyses indicates that the reaction rate-limiting step occurs after the chemical formation of ALA
(28). This observation, together with the evidence for structural repositioning of a flexible loop
over the active site, has led to the proposal that the ALAS-catalyzed reaction is at least partly
limited by a closed-to-open conformational transition that regulates the release of ALA from the
active site (29). Even though the validity of this hypothesis needs to be examined, possibly by
characterizing the rates of the conformational transitions, some evidence in its favor was
provided by Lendrihas et al. (33) when multiple mutations were introduced in the flexible active
site loop of mALAS2 and it was demonstrated that the kcat values of some variants were
increased in comparison to the wild-type enzyme. The authors concluded that the mutations
affected the ability of the enzyme variants to stabilize the closed conformation, resulting in faster
reversion to the open conformation during product release (33).

Differential regulation of the ALAS1 and ALAS2 isoforms
In mammals, there are two different isoforms of the ALAS gene localized on different
chromosomes: the non-specific isoform, ALAS1, is ubiquitously expressed in all tissues including
erythroid and has been mapped to chromosome 3p21.1 (34); the erythroid-specific isoform,
ALAS2, has been mapped to Xp11.21 (35) and is only expressed in erythroid cells, where it
serves to meet the high requirements for heme during erythropoiesis. Furthermore, as discussed
in the following pages, the two isoforms are regulated by different mechanisms.
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Transcriptional and translational regulation of ALAS1
During its transcription, the ALAS1 gene is regulated in a heme-dependent manner
through a classical feedback mechanism where inhibition of transcription occurs upon increased
concentrations of intracellular heme (1). There are two different mechanisms that regulate the
transcription of ALAS1. The first mechanism involves heme-dependent regulation of the
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) expression by the hemeresponsive, nuclear receptor Rev-erbα (36). PGC-1α is a coactivator that up-regulates the
expression of ALAS1 through the recruitment of the transcription factors nuclear respiratory
factor-1 (NRF-1) and FOXO1 to the respective NRF-1 and insulin regulatory elements (InsRE)
located in the promoter of the ALAS1 gene (37). Increase in the intracellular levels of heme
results in the binding of heme to Rev-erbα and recruitment of the repressor complex nuclear
receptor co-repressor/histone deacetylase 3 (NCoR/HDAC3) to repress the transcription of PGC1α, which decreases the expression of ALAS1 (36). It is important to note that increased
concentration of glucose also results in suppression of the ALAS1 gene in an insulin-dependent
manner (37). This is accomplished by phosphorylation of FOXO1 through an insulin-mediated
pathway and disruption of the interaction with PGC-1α (37). In the second mechanism, increased
concentrations of intracellular heme result in the up-regulation of the transcription factor, early
growth response 1 (Egr-1), which together with its major co-repressors NAB1/NAB2 binds to
heme responsive elements located in the proximal promoter region of ALAS1 (38). This results in
down-regulation of ALAS1.
Even though the regulation of mammalian ALAS1 at the level of translation is poorly
characterized, certain reports exist that translation is adversely affected by increased
concentration of hemin (38, 39). Specifically, from in vitro studies it was concluded that
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increased levels of hemin destabilized ALAS1 mRNA in hepatocytes (39), and decreased the rate
of translation of ALAS1 in polysomes that were isolated from hepatocytes (40).

Post-translational regulation of ALAS1
Like many other mitochondrial proteins, ALAS is synthesized in the cytosol as a
precursor protein, whose N-terminal pre-sequence is necessary for its translocation into
mitochondria (41). Once the enzyme is localized in the mitochondrial matrix, the pre-sequence is
processed by a yet to be identified peptidase, resulting in the formation of the mature enzyme.
Even though the pre-sequence is present in the ALAS1 and ALAS2 proteins, the amino acid
sequence identity between their pre-sequences is only 24 % (41). However, conserved motifs,
termed heme regulatory motifs (HRM), are present in the presequences, and are characterized by
a peptide sequence whose core consists of an invariant Cys-Pro dipeptide (41). Besides two
HRMs that are present in the presequence, another HRM was also identified in the mature
protein (41). Lathrop and Timko (41) demonstrated the importance of these HRMs in regulating
mitochondrial targeting by showing that hemin inhibits the translocation of precursor ALAS2
into isolated mitochondria, and that the hemin-dependent inhibition can be mainly prevented
upon replacement of the cysteines in either HRM with serines, strongly implicating that the
inhibition is mediated by the binding of hemin to the HRMs. These findings were supported by
the in vivo analyses of Munakata et al. (42) using quail fibroblasts, where the researchers
demonstrated that the translocation of ALAS1 into mitochondria is inhibited by hemin, and that
this process can be reversed upon mutations of the invariant HRM cysteines with serines.
However, the authors observed hemin-dependent inhibition only of ALAS1, and not ALAS2,
suggesting differences in the physiological regulation of the two isoenzymes (42).
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Besides inhibiting the translocation of ALAS1, hemin was also shown to affect the
stability of ALAS1 in mitochondria through proteolytic degradation. This degradation of ALAS1
is mediated in a heme-dependent manner by the Lon peptidase 1, although it is not understood
how the enzyme in the presence of heme is marked for proteolytc degradation (43).

Transcriptional regulation of ALAS2
The regulation of the ALAS2 gene appears to be mediated by transcription factors that are
essential for erythropoiesis. Kramer et al. (44) conducted functional analyses of the murine
ALAS2 gene to identify the promoter region that is essential for optimal transcriptional
activation, revealing an important role of the initial 714-bp of the proximal promoter. In this
region, numerous putative regulatory elements were identified for the binding of erythroid
transcriptional factors including: GATA-1, the erythroid Kruppel-like factor (EKLF)/Sp1, NFE2, and hypoxia inducible factor-1 (HIF-1) (44). Two proximal GATA-1 binding sites were
found to be necessary for optimal transcriptional activation (44).
Hofer et al. (45) reported that hypoxic conditions (1 % O2) up-regulate the expression of
the mALAS2 gene. Under hypoxic conditions, HIF-1 is known to up-regulate the expression of
numerous genes essential for erythropoiesis including erythropoietin, transferrin, and the
transferrin receptor (45). However, mutations in the putative HIF-1 binding site in the proximal
promoter region of mALAS2 revealed that the hypoxic up-regulation is independent of this region
(45). Further studies by Zhang et al. (46) with human ALAS2 corroborated up-regulation of the
gene under hypoxic conditions. The authors also identified three putative responsive elements for
binding of HIF-1 located downstream of the human ALAS2 gene. Reporter gene analyses and
mutagenesis studies had shown that these responsive elements are necessary for optimal
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transcriptional activation, and chromatin immunoprecipitation had shown HIF-1 to associate
with the downstream responsive elements (46).
Interestingly, introns 1 and 8 of the human ALAS2 gene were found to act as enhancers of
transcriptional activation (47). Within intron 8, two CACCC boxes and one GATA motif were
shown to be necessary for the enhancement of activity. These regions associate with Sp1 and
GATA-1, although ectopic expression of the two proteins in erythroid cells did not increase basal
expression of ALAS2, suggesting the involvement of a yet to be identified transcription factor
necessary for activation (47).

Translational regulation of ALAS2
Through binding to iron responsive elements (IRE), iron regulatory proteins (IRPs) are
known to regulate the level of mRNA translation of several proteins essential for iron and heme
metabolism (48). IREs were identified in the mRNAs sequences of the following proteins:
ferritin (49), transferrin receptor 1 (TfR1) (50), ferroportin (51), divalent metal transporter 1
(52), and ALAS2 (53). The binding of IRP to the IRE might inhibit or stimulate translation,
depending on the localization of the IRE (48). If the IRE is present in the 5’ untranslated region
of the mRNA (e.g., ALAS2 and ferritin), then binding of IRP will inhibit translation (48),
supposedly by preventing the binding of the 43s translation initiation complex (54). In contrast,
association of IRP with IREs localized in the 3’ untranslated regions of mRNAs (e.g., TfR1) tend
to stimulate translation by minimizing RNAse mediated degradation (48). Two different IRPs
have been identified that bind to IREs in iron depleted cells. IRP1 is a bifunctional protein that
associates with IREs under iron depleted conditions, whereas upon iron repletion, its iron-sulfur
cluster is assembled and the protein functions as a cytosolic aconitase (55). In contrast, during
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iron repletion, IRP2 is degraded by the proteasome through a mechanism that involves ironmediated oxidation and ubiquitination (56). This translational mechanism mediated by IRPs
closely regulates heme and iron metabolism, allowing for the translation of ALAS2 and ferritin
to occur during iron repletion, which would result in the sequestration of iron in heme or ferritin,
and thus, preventing its toxic buildup (1). During iron deficiency, in contrast, the biosynthesis
and accumulation of toxic porphyric intermediates is prevented by inhibition of ALAS2
translation through the binding of IRPs to its mRNAs (1).

Disorders associated with mutations in the ALAS2 gene
X-linked sideroblastic anemia (XLSA) is a hematopoietic disorder characterized by
microcytic, hypochromic anemia, and in specific cases, systemic iron overload (57). XLSA
results from loss-of-function mutations in the ALAS2 gene, and rarely, mutations in the proximal
promoter region (57). Since the ALAS2 gene is located on the X-chromosome, the pattern of
inheritance is X-linked, predominantly affecting males, although females are also affected as a
result of lyonization (57). Prophylaxis of the disease primarily includes management of the
anemia and prevention of iron overload. About ¾ of patients respond to treatment with
pyridoxine, which like PLP is another B6 vitamer (57).
Astner et al. (19) used the crystal structure of R. capsulatus ALAS to map specific XLSA
mutations on the enzyme. Mutations were assigned in four groups depending on the proximity to
the active site: 1) ALAS2 mutations present in pyridoxine-responsive patients, which tend to
cluster in the PLP-binding site and affect the binding or positioning of the cofactor, 2) Mutations
that disrupt the integrity of the active site by altering amino acids involved in catalysis, substrate
binding or positioning, and are typically present in patients who are not responsive to pyridoxine
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treatment, 3) Mutations in amino acids located in the protein interior, distant from the active site,
that may impact stability or structural integrity which may weaken binding of substrates and/or
PLP cofactor, and thus hinder catalysis, and 4) Mutations on the protein surface that impede
protein-protein interactions and/or affect protein stability.
X-linked dominant protoporphyria (XLDPP), results from gain-of-function mutations in
the ALAS2 gene (58). The first case of XLDPP was reported in 2008, and in contrast to other
porphyrias, where mutations either decrease the enzymatic activity or stability, XLDPP
mutations result in proteins whose catalytic activity is increased over the wild-type enzyme (58).
Clinically, XLDPP is characterized by an excessive accumulation of protoporphyrin IX and zincprotoporphyrin in erythrocytes, resulting in photosensitivity and liver complications (58). The
increased ALAS2 activity leads to protoporphyin production in quantities greater than the
available ferrous iron for heme synthesis. All of the identified XLDPP mutations fall into the last
protein-coding exon of the ALAS2 gene and result in frameshifts that lead to substitution or
deletion of the 20 C-terminal amino acids of ALAS2 (58).

Contents of the dissertation
The central focus of this dissertation is ALAS. Chapter II deals with the characterization
of unstable reaction intermediates and reaction selectivity, with a particular emphasis on the
hysteretic kinetic behavior detectable upon reaction of ALAS with non-physiological substrates
and products. Chapter III focuses on the importance of N150 in establishing a catalytic balance
between the forward and reverse reactions. In chapter IV, evidence is provided that ALAS can
function as a catalytically active molten globular enzyme under specific pH and temperature
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dependent conditions. Finally, chapter V provides a summary of the results and their
significance.
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Chapter Two
Unstable reaction intermediates and hysteresis during the catalytic cycle of
5-aminolevulinate synthase2

Abstract
5-Aminolevulinate (ALA), an essential metabolite in all heme-synthesizing organisms,
results from the pyridoxal 5’-phosphate (PLP)-dependent enzymatic condensation of glycine
with succinyl-CoA in non-plant eukaryotes and some bacteria. The predicted chemical
mechanism of this ALA synthase (ALAS)-catalyzed reaction includes a transient glycine
quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using liquid
chromatography coupled with tandem mass spectrometry to analyze the products from the
reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we
directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate
intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow
absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate
upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate,
the external aldimine predominates over the glycine quinonoid intermediate. When instead of
glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the
L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was
not detected in the T148A-catalyzed L-serine external aldimine formation. These results with
2

Note to reader. Portion of this research was originally published in the Journal of Biological Chemistry (1).
[Stojanovski et al. Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate
synthase: Implications from using pseudo and alternate substrates and a promiscuous enzyme variant. J. Biol.Chem.
2014, 289:22915-22925. © The American Society for Biochemistry and Molecular Biology]
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T148A, a mALAS2 variant, which, in contrast to wild-type mALAS2, is active with L-serine,
suggest that the active site T148 modulates the strict specificity of ALAS toward the amino acid
substrate. The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed
as a lag in the ALA external aldimine formation progress curve), consistent with conformational
changes governing the dissociation of ALA from ALAS.

Introduction
5-Aminolevulinate synthase (ALAS) catalyzes the condensation between glycine and
succinyl-CoA to generate CoA, CO2, and ALA (1-3). This reaction is the first, and main
regulatory, step of heme biosynthesis in mammals. There are two isoforms of the mammalian
ALAS gene: a non-specific and ubiquitously expressed isoform (ALAS1) and an erythroidspecific isoform (ALAS2) (2, 3). Loss-of-function mutations in the human ALAS2 gene result in
X-linked sideroblastic anemia (4), whereas gain-of-function mutations lead to X-linked dominant
protoporphyria (5).
ALAS belongs to the α-oxoamine synthase family of PLP-dependent enzymes, whose
members catalyze a condensation between a small amino acid and an acyl-CoA thioester (2, 610). The enzyme is a homodimer with its active site located at the dimeric interface (11). At least
two different conformations define ALAS: a catalytically incompetent, open conformation and a
catalytically competent, closed conformation (12, 13). Interconversion between these two
conformations appears closely linked to catalysis (13, 14). Namely, the rate limiting step of the
overall ALAS-catalyzed reaction is proposed to represent a conformational rearrangement from
the closed to the open conformation, which is concomitant with the release of ALA from the
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active site (13, 14). However, how the protein conformational changes are reflected in the last
steps of the ALAS kinetic mechanism has not yet been examined.
The proposed sequence of reaction events catalyzed by ALAS is outlined in Scheme 2.1.
The initial catalytic event involves displacement of the Schiff base linkage between a conserved,
active site lysine [(i.e., K313 in murine ALAS2 (15)] and the PLP cofactor (I) by the incoming
glycine substrate to form an external aldimine (II). Removal of one of the two glycine α-carbon
hydrogen atoms results in a quinonoid intermediate (III). A Claisen condensation of this
intermediate (III) with the succinyl-CoA substrate leads to CoA release and generation of the ketoacid aldimine complex (V), which then decarboxylates to yield a second quinonoid
intermediate, the quinonoid of the ALA product (VII). Findings from early radiolabeling studies,
using Rhodobacter sphaeroides ALAS and stereospecifically tritiated pro-R and pro-S
enantiomers of glycine, allowed investigators to reach two major conclusions: 1) ALAS
catalyzes the abstraction of the pro-R proton of glycine, giving a stabilized carbanion, the
quinonoid intermediate (III), and

2) the postulated ALAS-bound 2-amino-3-ketoadipate

intermediate is enzymatically decarboxylated (16, 17). Subsequently, two conserved, active site
amino acids, a lysine, which is linked through a Schiff base to PLP, and a histidine, located
directly above the plane of the PLP ring, (i.e., K313 and H207 in murine ALAS2), were
identified as the catalytic amino acids involved in the proton abstraction and decarboxylation
steps, respectively (14, 18) (Scheme 2.1).
Despite the efforts made in the last decade towards identifying the specific reaction
intermediates (i.e., Scheme 2.1, III and V) and defining a general reaction mechanism for the oxoamine synthase family (2, 6-8, 19, 20), direct evidence of the chemical and spectroscopic
nature of these intermediates has been unattainable. Kerbarh et al. (19) used the methyl ester of
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Scheme 2.1. Proposed chemical mechanism for the reaction catalyzed by ALAS. In the resting state,
PLP binds covalently to an active site lysine as an internal aldimine (I) [PLP-K313 internal aldimine in
mALAS2]. The entry of glycine in the active site proceeds with the formation of an external aldimine (II).
Removal of the pro-R proton of glycine results in formation of a first quinonoid intermediate (III), which
facilitates the condensation with succinyl-CoA and subsequent release of the CoA moiety (IV). When the
resulting 2-amino-3-ketoadipate intermediate (V) is decarboxylated (H207-assisted decarboxylation in the
mALAS2 reaction), an enol intermediate is formed (VI) which is in rapid equilibrium with a second
quinonoid intermediate (VII). The final reaction intermediate is the ALA external aldimine (VIII).

L-alanine as a pseudo-substrate to establish that the proposed quinonoid intermediate in the 8amino-7-oxononanoate synthase (AONS)-catalyzed reaction resulted from proton abstraction,
and not decarboxylation, of the AONS-alanine external aldimine. Similarly, formation of the
initial quinonoid intermediate could be spectroscopically observed upon binding of either glycine
or glycine and succinyl-CoA to R. sphaeroides ALAS (21). The monitoring of this quinonoid
intermediate was clearly facilitated in the R. capsulatus ALAS-catalyzed reaction by substituting
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glycine with O-methylglycine (22), as the resulting methyl ester of the β-ketoacid-aldimine could
not undergo enzymatic decarboxylation, and thus accumulated. However, even with the
significant acceleration of the rate of quinonoid intermediate formation upon succinyl-CoA
binding to ALAS (13, 23), neither the spectroscopic detection of the first quinonoid intermediate
(Scheme 2.1, III) nor the determination of the chemical nature of the predicted 2-amino-3ketoadipate intermediate (V) in the mALAS2-catalyzed reaction have yet been achieved, mainly
due to the transient and unstable nature of the III and V intermediates (3, 14).
In contrast to the strict specificity for glycine as the only amino acid substrate, ALAS can
utilize other acyl-CoA derivatives in addition to succinyl-CoA (24, 25). An important
determinant in the specificity of ALAS toward the amino acid substrate is the positioning of a
perfectly conserved active site threonine (22, 25). In fact, mutation of this threonine in ALAS
from R. sphaeroides (25) or R. capsulatus (22) altered the amino acid substrate specificity of the
enzyme. However, the kinetic, mechanistic, and conformational dynamic bases for this alteration
remain unknown.
Here we report the direct identification of the 2-amino-3-ketoadipate intermediate,
(Scheme 2.1, V) using glycine and O-methylglycine as substrate and pseudo-substrate,
respectively, and a combination of stopped-flow kinetics and liquid chromatography coupled
with tandem mass spectrometry (LC-MS/MS). This finding, together with the spectroscopic
detection of the first quinonoid intermediate (Scheme 2.1, III) and consequent calculation of the
rate constant associated with its formation, supports the occurrence of these two intermediates in
the pathway of the ALAS-catalyzed reaction and confirms that the quinonoid intermediate (III)
stems from deprotonation rather than decarboxylation of the ALAS-glycine external aldmine
(Scheme 2.1, II). Further, and in contrast to the physiological glycine substrate, mALAS2
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displayed hysteresis with L-serine, as indicated by the lag phase in the progress curve for the
mALAS2-serine external aldimine production. We propose that this hysteretic behavior
emanates from structural rearrangements induced by the different orientation of the bound Lserine in the mALAS2 active site.

Materials and methods
Reagents
The following reagents were obtained from Fisher Scientific: glycine, O-methylglycine
(also known as glycine methyl ester, glycine O-methyl ester, methyl glycinate and methyl 2aminoacetate), potassium phosphate monobasic, potassium phosphate dibasic, HEPES, glycerol,
HPLC grade methanol, HPLC grade acetonitrile, and sodium hydroxide. 5-Aminolevulinate
hydrochloride was from Acros Organics, and L-serine, pyridoxal 5’-phosphate, deuterated
glycine, and trimethylchlorosilane were from Sigma-Aldrich.

Construction and isolation of the T148A variant
The T148A variant was obtained by screening a library of mALAS2 variants for ALAS
activity. Briefly, the codons for T148 and N150 of mALAS2 were simultaneously randomized
using degenerate oligonucleotides. To screen the shuffling library for functional variants, we
reversed the phenotype of Escherichia coli hemA– (HU227) cells (26), which can survive only if
they harbor functional ALAS or if ALA (or hemin) is added to the medium (27). DNA
sequencing templates were prepared from colonies recovered on the selective medium and the
T184A-encoding mutation was then identified by DNA sequencing.
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Overproduction and purification of wild-type mALAS2 and T148A variant
Protein overproduction and purification were performed as described previously (28).
Following lysis of the cells, all purification steps were performed in one day and the
concentrated, purified protein was stored under liquid nitrogen. Protein purity was assessed by
SDS-PAGE. Protein concentrations were determined spectroscopically by monitoring the
absorbance at 280 nm and using a molar extinction coefficient of 42860 M-1 cm-1 based on the
mALAS2 amino acid sequence.

Synthesis of deuterated O-methylglycine
Deuterated O-methylglycine was prepared from deuteroglycine and methanol at room
temperature in the presence of trimethylsilane as previously described (29).

mALAS2-catalyzed reaction with either glycine or O-methylglycine
mALAS2 was reacted with glycine, O-methylglycine or deuterated O-methylglycine and
succinyl-CoA in 300 µL of 20 mM HEPES, pH 7.5, containing 10% (v/v) glycerol, at 30 °C for
120 minutes. The final concentrations in the reaction assays were 20 µM mALAS2, 100 μM
succinyl-CoA, and 100 mM glycine, O-methylglycine or deuterated O-methylglycine. The
control assay reactions were run under the above experimental conditions (i.e., same buffer,
temperature and time) but solely with 1) mALAS2, 2) mALAS2 and glycine, 3) mALAS2 and
O-methylglycine, 4) mALAS2 and deuterated O-methylglycine and 5) mALAS2 and succinylCoA. All of the above experimental and control reactions were run in duplicates, such that the
reactions in one of the two sets were stopped by precipitation with 50% (vol) trichloroacetic acid.
Briefly, trichloroacetic acid was added to each of these assay reactions (1:1, vol:vol), the
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precipitated protein was removed by centrifugation, and the supernatant was stored in liquid
nitrogen until the reaction intermediates present in the supernatant were analyzed by LC-MS/MS
at the Sanford/Burnham Medical Research Institute, Lake Nona, Orlando, FL.

Sample preparation for mass spectrometry
Twenty μl of each sample, previously thawed to room temperature, was combined with
250 μl of HPLC grade acetonitrile in a 650 μl micro-centrifuge tube and vortexed for 5 minutes
on a multi-tube vortex. The samples were then sonicated for 1 minute and centrifuged for 10
minutes. The supernatant was removed to a clean 96-well plate and evaporated to dryness under
high purity N2 gas at 60 oC. Prior to analysis by LC-MS/MS, the samples were reconstituted in
200 μl of HPLC grade water, vortexed and centrifuged.

Synthesis of the methyl ester of 2-amino-3-ketoadipate
5-Amino-6-methoxy-4,6-dioxo-hexanoic acid (i.e., the methyl ester of the putative 2amino-3-ketoadipate reaction intermediate) was synthesized from benzyl alcohol as described in
Appendix 1.

Data acquisition
Data acquisition, peak integration, and sample quantitation were performed using a Dell
Precision 390 Desktop Computer with an Intel Core 2 Duo Processor, Microsoft Windows XP
Professional and Analyst Software Version 1.4.2.
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Separation of the reaction intermediates by ultra-high pressure liquid chromatography
(UPLC)
UPLC was performed using a Waters Acquity UPLC system (Waters Corp., Milford,
MA). Chromatographic separation of the reaction intermediates was achieved using an Acquity
BEH C18 1.7 µ 2.1 x 50 mm UPLC column (Waters Corp.). A 0.1% formic acid in water and
0.1% formic acid in acetonitrile solutions were prepared as mobile phases A and B, respectively.
The flow rate was set at 0.4 mL/min and the injection volume was set at 1 µl. A linear gradient
separation was used, with 10% of mobile phase B from 0 to 0.50 min, then 10% to 95% of
mobile phase B over 0.50 min, holding for 0.80 min, after which returning to 100% A in 2.00
min for initial conditioning.

Detection

and

characterization

of

the

“trapped”

intermediate

by

liquid

chromatography coupled with tandem mass spectrometry (LC-MS/MS)
LC-MS/MS analysis (i.e., mass detection) was performed using an Applied Biosystems
API4000 QTrap LC/MS/MS instrument (AB Sciex, Foster City, CA) equipped with a Turbo
Ionspray (TIS) source. The mass spectrometer was operated in a positive ion mode monitoring 4
transitions for ALAS reaction intermediates using optimized analyte-dependent parameters. The
structure for the proposed “trapped” intermediate, 5-amino-6-methoxy-4,6-dioxo-hexanoic acid,
is given in Fig. 2.1.

Stopped-flow absorption spectroscopy experiments
A Kintek stopped-flow apparatus (model SF-2001) was used to monitor transient changes
in absorbance (at 420 nm or 510 nm) following rapid mixing of enzyme (mALAS2 or T148A
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variant) and ligands (glycine, L-serine or ALA). All reactions were performed at 18 ºC in 50 mM
phosphate (37 mM K2HPO4/13 mM KH2PO4), pH 7.5, containing 10% glycerol (v/v). For the
reaction between wild-type mALAS2 and glycine, one of the syringes contained 60 µM wildtype mALAS2 in the above 50 mM phosphate buffer, pH 7.5, whereas the other syringe
contained 200 mM glycine in the same buffer. The final concentrations of the reactants upon
mixing are reported in the figure legends. The same buffer (composition and concentration) and
enzyme and amino acid substrate concentrations were used in the reaction between wild-type
mALAS2 (or T148A variant) and L-serine. For the reaction between wild-type mALAS2 and
ALA, one of the syringes contained 60 µM wild-type mALAS2 in the above 50 mM phosphate
buffer, pH 7.5, while the other syringe contained 20 mM ALA in the same buffer. Prior to
reacting mALAS2 with ALA, the 1 M ALA-HCl stock was neutralized with an equal volume of
1 M NaOH. The final concentrations of wild-type mALAS2 and ALA in the observation
chamber were 30 µM and 10 mM, respectively. Each time course for the different monitored
reactions represents the average of three or more data sets. The time course data were fitted to
either a single- or two-exponential equation (Eq 2.1) using the Kintek stopped-flow software

(Eq. 2.1)
where At is the absorbance at time t, a is the amplitude of each phase, k is the observed rate
constant for each phase and c is the final absorbance.
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Results
Identification of the Claisen condensation intermediate by LC-MS/MS
The detection and characterization of the mALAS2-bound intermediate upon the reaction
of mALAS2 with O-methylglycine (or deuterated O-methylglycine) and succinyl-CoA was
carried out using LC-MS/MS. Samples were analyzed by full-scan Q1 positive and negative
modes and multiple reaction monitoring (MRM) positive mode for the predicted ALAS
intermediate (Fig. 2.1). A signal at 189-190 m/z was observed during the full scan mode in
positive ionization, as expected for the methyl ester of the-ketoacid aldimine complex (i.e., the
5-amino-6-methoxy-4,6-dioxohexanoic acid intermediate; Scheme 2.1, structure V; Figure 2.1A,
Inset). To confirm this assignment, 5-amino-6-methoxy-4,6-dioxo-hexanoic acid was
synthesized, the analyte-dependent parameters were optimized, and the reaction samples were reanalyzed for the intermediate in the MRM mode. The peak corresponding to the trapped methyl
ester of the -ketoacid intermediate was significantly present in the samples in which mALAS2
was reacted with O-methyl glycine and succinyl-CoA (Figure 2.2).

Reaction between glycine and wild-type mALAS2
The reaction between wild-type mALAS2 and glycine was examined by monitoring the
changes in absorbance, at either 420 nm or 510 nm, as a function of time, using stopped-flow
spectroscopy (pH 7.5/18 °C). The absorbance increase at 420 nm was previously assigned to the
formation of the glycine external aldimine, while that observed at 510 nm was ascribed to
quinonoid intermediate formation (13). Due to the high Km for glycine [i.e., 12 mM (30)] and the
difficulty in reaching mALAS2 concentrations greater than 600 M, the reaction was performed
using multi-turnover conditions, with the substrate concentration in excess over that of the

39

Figure 2.1. Analysis of the trapped intermediate in the ALAS-catalyzed reaction of O-methylglycine
with succinyl-CoA by LC-MS/MS. (A) UPLC profile of the reaction sample indicating that the retention
time of the major species, which has a mass ion spectrum peak at 188.9 m/z, is 0.44 min. (B) MS/MS
scan spectrum (abundance vs. m/z) of the 0.44 min-fraction derived from the reaction sample indicating
that the predominant species, with a peak at 188.9 m/z, is consistent with the molecular mass of 189.17
for the predicted intermediate, 5-amino-6-methoxy-4,6-dioxohexanoic acid (inset in (A)).

Fig. 2.2. MRM chromatogram for the intermediate in the mALAS2-catalyzed reaction of Omethylglycine with succinyl-CoA
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enzyme. The time course monitored at 420 nm for the reaction of 30 µm wild-type mALAS2
with 100 mM glycine, at pH 7.5 and 18 ºC, was best described by a monophasic process with an
observed rate constant of 0.080 ± 0.001 s-1 (Fig. 2.3A). Similarly, the time course data for the
same reaction, when monitored at 510 nm, were best fit to a single-exponential equation,
yielding virtually the same value for the observed rate constant (0.070 ± 0.001 s-1) (Fig. 2.3B).
However, if one assumes that the extinction coefficients of the two quinonoid intermediates are
similar, it becomes apparent that the extent of the formed glycine external aldimine and glycine
quinonoid intermediates varied considerably. Comparison between the extent of glycine
quinonoid intermediate produced in the absence of succinyl-CoA (Fig. 2.3B), as assessed by the
maximum absorbance amplitude at 510 nm, and that in the presence of 100 M succinyl-CoA
(data not shown), indicated that the amount of quinonoid intermediate formed in the absence of
succinyl-CoA was approximately 4% of that produced in the presence of the succinyl-CoA
substrate (i.e.,

).

These results suggest that even though there is some

interconversion between the two intermediates, the external aldimine is the predominant
intermediate when the enzyme reacts with glycine in the absence of succinyl-CoA.

Reaction of L-serine with either wild-type mALAS2 or T148A
To address the question of the ALAS amino acid substrate specificity, the pre-steady state
reaction between 30 µm wild-type mALAS2 and 100 mM L-serine, at pH 7.5, 18 ºC, was
monitored by following the change in absorbance at 420 nm with time (Fig. 2.4A). A distinctive
lag phase was observed in the first 1.0 s of the kinetic trace for the external aldimine formation
between L-serine and wild-type mALAS2 (Fig. 2.4A), which was not detected upon reaction
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with glycine (Fig. 2.3A). Further, the reaction with L-serine follows a biphasic kinetic process
(Fig. 2.4A).

Figure 2.3. Reaction between wild-type mALAS2 (30 µM) and glycine (100 mM). (A) Progress curve
for the formation of the glycine external aldimine monitored at 420 nm. The data (open purple circles)
were fit to a single-exponential equation with an observed rate constant (k1) of 0.080 ± 0.001s-1 and
amplitude (A1) of 4.00x10-3 ± 0.01x10-3. (B) Progress curve for the formation of the glycine quinonoid
intermediate monitored at 510 nm. The data (open purple circles) were fit to a single-exponential equation
with an observed rate constant (k1) of 0.070 ± 0.001s-1 and amplitude (A1) of 0.80x10-3 ± 0.01 x 10-3.

The pre-steady state reaction between 30 µM T148A mALAS2 and 100 mM L-serine (at
pH 7.5 and 18 ºC) was also investigated by monitoring the progress of external aldimine
production, as assessed by the increase in absorbance at 420 nm. The T148A variant, in contrast
to wild-type mALAS2, is active when L-serine and succinyl-CoA are the substrates (data not
shown). Interestingly, the lag phase observed in the progress curve for the wild-type mALAS242

catalyzed reaction with L-serine was not observed with the T148A variant under identical
experimental conditions (Fig. 2.4B). This implies that the lag phase observed for the reaction
between L-serine and wild-type mALAS2 most likely resulted from unfavorable steric clashes
with active site amino acids; thus when the active site architecture is modified, as in the T148A
variant, the binding of L-serine can take place, presumably by circumventing any unfavorable
steric clashes.

Figure 2.4. Reaction of either wild-type mALAS2 or T148A variant (30 µM) with L-serine (100
mM). (A) Progress curve for the formation of the L-serine-mALAS2 external aldimine. The data points
were fit to a two-exponential equation yielding the observed rate constants (k1 and k2) and amplitudes (A1
and A2): k1=2.5 ± 0.2 s-1and A1=1.70x10-3 ± 0.01x10-3 for the fast phase, and k2=0.070 ± 0.001 s-1 and
A2=3.80x10-3 ± 0.01x10-3 for the slow phase. The inset shows the first 10 s of the reaction. (B) Progress
curve for the formation of the L-serine-T148A external aldimine. The data were fit to a single-exponential
equation yielding the observed rate constant (k1) of 0.070 ± 0.001 s-1 and the amplitude (A1) of 6.80x10-3
± 0.01x10-3.
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Reaction between ALA and wild-type mALAS2
The time dependence of the pre-steady state reaction between 30 µM wild-type mALAS2
and 10 mM ALA, at pH 7.5 and 18 ºC, was examined by monitoring the change in absorbance at
either 420 nm (Fig. 2.5A) or 510 nm (Fig. 2.5B). While a distinctive kinetic lag phase of 0.5
seconds was observed in the progress curve for the formation of the ALA-ALAS external
aldimine (Fig. 2.5A), no kinetic lag phase was detectable during the ALA-quinonoid
intermediate formation (Fig. 2.5B).

Figure 2.5. Reaction between wild-type mALAS2 (30 µM) and ALA (10 mM). (A) Progress curve for
the formation of the ALA-mALAS2 external aldimine as monitored at 420 nm. The data points were fit to
a two-exponential equation yielding the observed rate constants (k1 and k2) and amplitudes (A1 and A2):
k1=4.7 ± 0.01 s-1 and A1=1.1x10-3 ± 0.07x10-3 for the fast phase, and k2=0.37 ± 0.003 s-1 and A2=5.2x10-3
± 0.02x10-3 for the slow phase. The inset shows the first 2.5s of the reaction. (B) Progress curve for the
formation of the ALA quinonoid intermediate as monitored at 510 nm. The observed rate constants (k1
and k2) and amplitudes (A) were: k1=0.61 ± 0.01 s-1 and A1=4.50x10-3 ± 0.07x10-3 for the fast phase, and
k2=0.08 ± 0.01s-1 and A2=1.50x10-3 ± 0.04x10-3 for the slow phase.
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Formation of the external aldimine and quinonoid intermediates were both best described
as biphasic processes. The observed rates for the fast and slow phases associated with the time
course at 420 nm were 4.70 s-1 and 0.37 s-1, respectively (Fig. 2.5A), whereas those pertinent to
the time course at 510 nm were 0.61 s-1 and 0.08 s-1 (Fig. 2.5B).

Discussion
In this study, we provide direct evidence for the presence of the first quinonoid and ketoacid reaction intermediates in the catalytic pathway of ALAS and examine the amino acid
substrate specificity and conformational transitions of ALAS by focusing on the hysteretic
behavior of the enzyme. Soon after ALAS was purified (31, 32) and PLP proven to be a cofactor
of the enzyme (31, 32), the major question about the ALAS mechanism centered on establishing
whether the external aldimine between glycine and ALAS (i.e., II in Scheme 2.1) would be
decarboxylated or deprotonated (16, 31, 33) to give a stabilized carbanion. Findings from
radiolabeling studies, using R. sphaeroides and stereospecifically tritiated glycine, clearly
pointed to the deprotonation route yielding a quinonoid intermediate (i.e., III in Scheme 2.1) (16,
33). Further, the deprotonation was stereospecific, with the exclusive removal of the pro-R
proton (16) and, ultimately, the pro-S proton of glycine retaining the S-configuration at C-5 of
ALA (17). This latter observation indicated not only that the inferred-amino--ketoadipate
intermediate (i.e., V in Scheme 2.1) was on the catalytic pathway, but also that its
decarboxylation was catalyzed by the enzyme (17, 34). However, corroborating the presence of
the condensation intermediate, resulting from the condensation of the glycine quinonoid
intermediate with succinyl-CoA has proven to be challenging. This is partly because the 2amino-3-ketoadipate intermediate is very reactive, undergoes a fast decarboxylation, and is

45

difficult to trap (14). Moreover, even if one could successfully trap the 2-amino-3-ketoadipate
intermediate on the enzyme, its spontaneous decarboxylation at physiological pH would still be
rapid (35).
Due to the chemical liability of the 2-amino-3-ketoadipate intermediate, which precluded
its direct detection, we resorted to using O-methylglycine as a pseudo-substrate to study the
ALAS-catalyzed reaction. Since the carboxyl group of O-methylglycine is protected against
decarboxylation, formation of the carbanion intermediate can only proceed by initial
deprotonation. Moreover, with this pseudo-substrate, the Claisen condensation can still occur,
yielding the methyl ester of the -ketoacid-aldimine complex, but the reaction cannot proceed
beyond this step, as the methyl ester of the -amino--ketoacid (or methoxy-4,6-dioxo-hexanoic
acid) intermediate cannot undergo decarboxylation. Indeed, when we used LC-MS/MS to
analyze the mALAS2-catalyzed product resulting from the reaction of mALAS2 with Omethylglycine and succinyl-CoA, a pronounced peak (188.9 m/z) was observed for the molecular
ion of the putative, more stable, condensation intermediate (Fig. 2.1), in good agreement with its
predicted molecular weight of 189.17. To verify that the 188.9 m/z peak was due to the
mALAS2-catalyzed formation of the Claisen intermediate, 5-amino-6-methoxy-4,6-dioxohexanoic acid was synthesized and analyzed using LC-MS/MS. In addition, a shift of +1 m/z was
apparent when deuterated O-methylglycine was the pseudo-substrate, further validating the
chemical nature of the condensation intermediate (data not shown). Our findings can probably be
extended to the reaction mechanism of other α-oxoamine synthases, particularly since it supports
an earlier report inferring the presence of the AONS-bound methyl ester of the condensation
intermediate (19).
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Until this study, detection of the first quinonoid intermediate in the mALAS2 catalytic
pathway (Scheme 2.1, III) had not been demonstrated. Clearly, the identification of the
condensation intermediate argues in favor of the first quinonoid (or glycine quinonoid) species
(Scheme 2.1, III), as this intermediate could only have been formed from deprotonation of the Omethylglycine pseudo-substrate. In prior transient kinetic studies conducted with mALAS2,
glycine and succinyl-CoA, it was deduced that the formation and decay of the glycine quinonoid
intermediate occurred too rapidly to be kinetically significant (13), and was demonstrated that
the addition of succinyl-CoA accelerated the rate of the reaction of mALAS2 with glycine by
several orders of magnitude (23). In the present study we reacted mALAS2 with glycine at 18
o

C, instead of 30 oC (13), and monitored the reaction by following the change in absorbance at

420 nm (Fig. 2.3A) and 510 nm (Fig. 2.3B). The glycine quinonoid intermediate could be
detected at 510 nm, further supporting the conclusion of the mass spectrometry results that wildtype mALAS2 catalyzes the abstraction of a proton from glycine. Even though the formation of
the glycine external aldimine and glycine quinonoid intermediates proceeded at similar rates
(Figs. 2.3A and 2.3B), in the absence of succinyl-CoA, the external aldimine outweighs the
quinonoid intermediate. In fact, the amplitude value representing the formation of the initial
quinonoid intermediate was estimated to be approximately 4% of the amplitude value for the
same intermediate when produced in the presence of the succinyl-CoA substrate. The
significantly reduced amplitude value for the formation of the quinonoid intermediate indicates
that this intermediate, in the absence of succinyl-CoA, is catalyzed by a small percentage of the
total enzyme population, which can, in part, explain the difficulties associated with the
spectroscopic detection of the glycine quinonoid intermediate.
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Unlike the reaction with glycine, the kinetic trace for the reaction between L-serine and
wild-type mALAS2 is characterized by a lag phase (Fig. 2.4A). Typically, a lag phase is
observed in the reaction progress curves of enzymes with hysteretic behavior (36). These
enzymes undergo conformational changes at a rate that is slower than that of the corresponding
chemical reaction (36). We propose that structural rearrangements induced by the entry of Lserine into the ALAS active site precede the formation of the serine-ALAS external aldimine.
While the specific structural rearrangements induced by L-serine binding remain to be defined, it
is entirely conceivable that the entry of L-serine into the tightly packed ALAS active site results
in steric clashes between L-serine and active site amino acids, and the generated conformational
strain hinders the ability of the enzyme to properly stabilize conformation favorable for catalysis
of the external aldimine. To provide a compatible interpretation for the orientation of L-serine
within the active site of ALAS, we modeled the L-serine external aldimine of Sphingomonas
paucimobilis serine palmitoyltransferase (SPT) in the active site of R. capsulatus ALAS (Fig.
2.6). These two enzymes belong to the α-oxoamine synthase family and share a conserved fold,
active site architecture, and catalytic mechanism. Interestingly, there are notable differences in
the positioning of the α-carboxyl group of the amino acid substrate: the α-carboxyl group of
glycine forms a salt bridge with R439, while the α-carboxyl group of L-serine is predicted to
interact with H207 (mALAS2 numbering; R. capsulatus numbering is indicated in Fig. 2.6).
Hence, during initial binding, L-serine can sterically clash with amino acids in the active site of
ALAS. The resulting conformational strain might be transient, and, once the external aldimine is
formed, the enzyme assumes a closed conformation similar to that adopted in the presence of its
physiological substrates. However, we cannot exclude the possibility that the binding of L-serine

48

stabilizes a catalytically incompetent conformation, distinct from the previously reported open
and closed conformations (12).

Figure 2.6. Model depicting the positioning of the L-serine external aldimine in the active site of
ALAS. The model was created by superimposing the L-serine external aldimine of S. paucimobilis SPT
(PDB file 2W8J) with the glycine external aldimine of R. capsulatus ALAS (PDB file 2BWP). L-serine is
shown in green and glycine in cyan. Succinyl-CoA was subsequently modeled into the active site by
superimposing the generated structure with the structure for the R. capsulatus●succinyl-CoA complex
(PDB file 2BWO), using PyMOL. R. capsulatus ALAS amino acids T83, H142, K248 and R374
correspond to mALAS2 T148, H207, K313 and R439, respectively

One amino acid within the active site of mALAS2 that can come to steric clashes with Lserine is T148. This amino acid modulates the amino acid substrate specificity of mALAS2, such
that its substitution with alanine endows the T148A variant with the capacity to utilize L-serine
as substrate (data not shown). According to our structural model, once the external aldimine is
formed, the L-serine α-carboxylate is about 2 Å apart from the T148 side chain methyl group
(Fig. 2.6). This orientation differs from that of the α-carboxylate of the glycine external aldimine,
which is oriented away from T148. Consequently, L-serine, by not orienting properly in the
active site of mALAS2, clashes with T148 during the formation of the external aldimine. This
hypothesis is supported by the absence of a lag phase in the progress curve for the T148A49

catalyzed serine external aldimine formation (Fig. 2.4B). The considerably smaller side chain of
alanine than of threonine provides a more open active site pocket in the T148A variant than in
wild-type mALAS2. Thus, in contrast to wild-type mALAS2, not only can L-serine be properly
oriented and succinyl-CoA accommodated, but also the condensation reaction can take place in
the active site of the T148A variant.
While the formation of the Ser-mALAS2 external aldimine was easily followed (Fig.
2.4A), the activity of mALAS2 with serine and succinyl-CoA could not be determined under
steady-state conditions (data not shown), as monitored by CoA production (37). These findings
indicate that the mALAS2-catalyzed condensation between L-serine and succinyl-CoA does not
proceed beyond external aldimine formation and suggest that succinyl-CoA fails to bind
productively to the active site, as evident from the absence of detectable CoA production. The
inability of succinyl-CoA to bind productively in the presence of L-serine probably stems from
the positioning of L-serine, whose α-carboxyl group is oriented differently from that of glycine
(Fig. 2.6). For the reaction between the amino acid substrate and succinyl-CoA to occur, the
former needs to interact with R439, as demonstrated with glycine (38). In the case of L-serine,
our model predicts that its α-carboxyl group interacts with H207 rather than R439, which in turn
would hamper the binding of succinyl-CoA due to steric clashes between the succinyl moiety
and the α-carboxyl group of L-serine (Fig. 2.6). Therefore, the interaction between the αcarboxyl group of the amino acid substrate and R439 is important for proper positioning of
succinyl-CoA into the active site. This is supported by data demonstrating that the conservative
mutation R439K results in a 20-fold decrease in the catalytic efficiency for succinyl-CoA, while
the R439L mutation is deleterious, implying that R439 has an important role in facilitating
productive binding of the substrates (38).
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The rate-limiting step in the ALAS-catalyzed reaction has been assigned to a
conformational change resulting from the reversion of the enzyme to the open conformation
during the release of ALA (14, 23). Characterization of the reaction with ALA revealed a lag
phase in the kinetic trace of the external aldimine formation (Fig. 2.5A), implying that the entry
of ALA in the active site induces potential conformational rearrangements. Since the ALAexternal aldimine (Scheme 2.1, VIII) is the final intermediate in the reaction pathway, it would
be interesting to examine in future studies whether its formation, or more likely, the dissociation
of ALA from PLP, induces conformational rearrangements within the active site that can
destabilize the closed conformation and facilitate reversion to the open conformation, resulting in
the release of ALA from the enzyme.
Upon close examination of the crystal structure of R. capsulatus ALAS, we identified an
alternative access channel to the active site, which possibly provides the path for entry of glycine
or exit of ALA (Fig. 2.7). This channel, distinct from that occupied by succinyl-CoA, can only
be seen in the open conformation structures. It covers amino acids from the N-terminal domain,
organized in an -helix and a loop (i.e., R. capsulatus ALAS amino acids 1-24) and amino acids
from the C-terminal domain making an -helix and a linker (i.e., R. capsulatus ALAS amino
acids 337-352). The active site glycine-rich loop (i.e., R. capsulatus ALAS amino acids 77-89)
from the opposite monomer also contributes to the architecture of this channel. Val-341 and Gly18, located approximately 10Å apart and in the open conformation, outline the entry of the
channel (Fig. 2.8). Actually, the active site loop and the C-terminal helix make up a structural
region in R. capsulatus ALAS that undergoes significant conformational changes during the
conversion from open to closed conformation (Fig. 2.8).
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X-linked sideroblastic anemia mutations localized to the human ALAS2 N-terminal helix and loop also led us to suggest a physiological relevance to this structural region of the
channel. These mutations [M154I, D159N, D159Y, T161A, and F165L (4, 12)] may perturb the
structural integrity of the channel and obstruct the entry of glycine to or ALA exit from the
active site. If a protein transporter, as recently suggested for the human SLC25A38 gene product
(39), is involved in the import of glycine to or the export of ALA from mitochondria, then it will
be important to examine whether the SLC25A38 transporter interacts with ALAS and whether
the channel amino acids participate in the protein-protein interactions.

Figure 2.7. Alternative channel for the entry of substrates into the active site of R. capsulatus
ALAS. (A) The alternative channel in the open and (B) closed conformations (PDB files 2BWN and
2BWO). This channel and the succinyl-CoA-specific channel are distinct. The N-terminal domain is
shown in cyan, the catalytic domain in gray and the C-terminal domain in magenta. The opposite
monomer is shown in yellow. Succinyl-CoA is shown in stick representation
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Figure 2.8. Differences in the positioning of C-terminal α-helix Val-341 in the open and closed
conformations. The open and closed conformations are shown in gray and cyan, respectively.
Monomers A and B (PDB file 2BWN) were superimposed using PyMOL.
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Chapter Three
Asn-150 of murine erythroid 5-aminolevulinate synthase is important in favoring the
catalytic balance toward 5-aminolevulinate formation over its non-productive
transformation into the quinonoid intermediate

Abstract
5-Aminolevulinate synthase (ALAS) catalyzes the first step in mammalian heme
biosynthesis, the pyridoxal 5’-phosphate (PLP)-dependent and reversible reaction between
glycine and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA). In Rhodobacter
capsulatus ALAS, apart from coordinating the positioning of succinyl-CoA, N85 has an
important role in regulating the opening of an active site channel. Here, we mutated the
analogous asparagine of murine erythroid ALAS to histidine (N150H) and assessed the effects of
this mutation on catalysis using steady-state and transient kinetic studies. Quinonoid intermediate
formation occurred with a significantly reduced rate for the N150H-catalyzed condensation of
glycine with succinyl-CoA during a single turnover. When the same forward reaction was
examined under multiple turnovers, the progress curve of the N150H reaction displayed a
prolonged decay of the quinonoid intermediate into the steady-state, distinct from the steep decay
in the wild-type ALAS reaction. This prolonged decay results from an accelerated transformation
of the product, ALA, into the quinonoid intermediate during the reverse N150H-catalyzed
reaction. In fact, while wild-type ALAS catalyzes the conversion of ALA into the quinonoid
intermediate at a rate 6.3-fold lower than the formation of the same quinonoid intermediate from
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glycine and succinyl-CoA, the rate for the N150H-catalyzed reverse reaction is 1.7-fold higher
than that of the forward reaction. We conclude that N150 is important in establishing a catalytic
balance between the forward and reverse reactions, by favoring ALA synthesis over its nonproductive transformation into the quinonoid intermediate. Mutations at this position could
perturb the delicate heme biosynthetic equilibrium.

Introduction
5-Aminolevulinate synthase (ALAS), a homodimeric, pyridoxal 5’-phosphate (PLP)
dependent enzyme, catalyzes the first and regulatory step in mammalian heme biosynthesis,
which is the condensation between glycine and succinyl-CoA to generate coenzyme A (CoA),
CO2, and 5-aminolevulinate (ALA) (1, 2). Loss-of-function and gain-of-function mutations in the
erythroid-specific ALAS gene (ALAS2) result in X-linked sideroblastic anemia (XLSA) and Xlinked dominant protoporphyria (XLDPP), respectively (3, 4), suggesting that the rate of ALA
synthesis is a closely regulated physiological process, ultimately ensuring that heme production
meets the requirements of developing erythroid cells during hemoglobinization, while averting
disturbances in porphyrin and iron metabolism that can result in cellular toxicity
The rate-limiting step of the ALAS-catalyzed reaction has been assigned to a closed-toopen conformational transition that coincides with ALA release from the active site (5-7). During
this conformational transition, the active site becomes more accessible to the solvent as a result
of segmental motions associated with the repositioning of an active site loop and a C-terminal
helix (8). Mutations in the flexible active site loop can increase the kcat by 30-fold and the
catalytic efficiency for succinyl-CoA by about 100-fold (9), implicating that wild-type ALAS
evolved away from catalytic power, which was probably an evolutionary necessity to minimize
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toxic build-up of highly reactive ALA-derived porphyric intermediates. This necessity is further
substantiated with results indicating that even subtle increases in the catalytic activity as a result
of mutations in the human ALAS2 gene can lead to the erythropoietic disorder XLDPP (4, 10).
Moreover, in order to avert the toxic accumulation of free mitochondrial iron that ensues with
inadequate ALA biosynthesis, an equally important evolutionary pressure must have shaped the
active site architecture of ALAS to minimize undesirable side reactions that could otherwise
inactivate the enzyme or generate products other than ALA. Two pieces of evidence supporting
this argument include: 1) the inefficacy of ALAS in catalyzing the abstraction of the pro-R
proton of glycine in the absence of succinyl-CoA (5, 6, 11), which eventually could result in
enzyme inactivation through abortive transamination, and 2) the strict substrate specificity of
ALAS toward glycine as the only reported natural amino acid condensing with succinyl-CoA
(11-13) (thus, minimizing the biosynthesis of products other than ALA). This specificity is
abolished upon mutating an invariant threonine present in an active site glycine-rich stretch,
suggesting that this region is important in defining the reaction selectivity (11-13). Furthermore,
because the ALAS-catalyzed reaction is reversible (14), catalytic balance between the forward
and reverse reactions must be in place to ensure that physiologically relevant concentrations of
ALA are available for unperturbed heme biosynthesis.
The postulated reaction mechanism for the ALAS-catalyzed reaction is shown in scheme
3.1. Two carbanions, termed quinonoid intermediates (λmax~510 nm), are generated during the
ALAS catalytic cycle for the condensation of glycine and succinyl-CoA (5-7, 11, 12, 14, 15).
An initial quinonoid intermediate is formed upon removal of the pro-R proton from the glycineexternal aldimine complex (Scheme 3.1, III) (11, 12, 14), while a second quinonoid intermediate
(henceforth referred as quinonoid intermediate II [Scheme 3.1, VII]) results from the
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decarboxylation of the 2-amino-3-ketoadipate condensation intermediate (5-7). The generated
enol, which is in rapid equilibrium with the quinonoid intermediate II, is then protonated to yield
the ALA-external aldimine (Scheme 3.1 , VIII) (7). Release of ALA from the active site, guided
by conformational transitions, represents the final step of the catalytic cycle. Since the stable
quinonoid intermediate II is also generated upon removal of the C5 proton of ALA during the
reverse reaction (5, 6, 11, 15), the active site of ALAS must have evolved to minimize the nonproductive transformation of ALA into the quinonoid intermediate II. However, the active site
region responsible for minimizing this non-productive transformation remains unknown.

Scheme 3.1. Postulated mechanistic cycle for the catalytic events in the active site of mALAS2. (I)
Internal aldimine complex, (II) glycine-external aldimine, (III) quinonoid intermediate I, (IV) glycinesuccinyl-CoA condensation intermediate, (V) 2-amino-3-ketoadipate intermediate, (VI) enol intermediate,
(VII) quinonoid intermediate II, (VIII) ALA-external aldimine.
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Recently, we have identified an alternative channel in Rhodobacter capsulatus ALAS
that serves as a potential path of entry for glycine to and ALA exit from the active site (Fig. 3.1)
(11). The architecture of this channel is shaped by amino acids from the C-terminal (i.e., R.
capsulatus ALAS amino acids 337-352) and N-terminal (i.e., R. capsulatus ALAS amino acids
1-24) domains of one monomer and by the glycine-rich stretch from the opposite monomer (i.e.,
R. capsulatus ALAS amino acids 77’-89’) (Fig. 3.1), which is important in defining the amino
acid substrate specificity. N85’ (N150’ of murine erythroid ALAS [abbreviated as mALAS2]) of
this glycine-rich stretch appears to play a particularly important role in mediating the opening
and closing of this channel. Upon careful analysis of the crystal structure of R. capsulatus ALAS
(8), we observed that, in the closed conformation, N85’ forms an H-bond with Q359 (Q424 of
mALAS2) of the flexible active site loop, resulting in closure of the channel (Figs. 3.1 and 3.2).
When ALAS reverts to the open conformation, this interaction is disrupted, and the side chain of
N85’ is reoriented away from the active site loop, which, in turn, results in opening of the
channel (Fig. 3.2). Apart from gating the active site from the solvent, N85’ plays a vital role in
positioning the carboxyl group of succinyl-CoA (8, 12), thus ensuring that the carbonyl group of
this substrate and the C-α of the glycine-external aldimine attain an orientation favorable for
condensation. Moreover, once condensation occurs, the succinyl-derived carboxyl group of the
resulting 2-amino-3-ketoadipate intermediate is expected to retain the interaction with N85’,
implicating an additional role of this amino acid in catalytic steps subsequent to condensation
(i.e., in reaction steps after IV of Scheme 3.1.).
Based on the postulated catalytic importance of this invariant asparagine, we have
performed extensive kinetic and equilibrium studies to assess the effects on catalysis that ensue
upon substituting N150’ of mALAS2 with a histidine. The data reveal that N150’ is essential in
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establishing a catalytic balance between the forward and reverse reactions by favoring ALA
synthesis over its non-productive transformation into the quinonoid intermediate II.

Figure 3.1. Alternative channel leading to the active site of R. capsulatus ALAS in the open (A) and
closed (B) conformations. In the closed conformation, the repositioning of the side chain of N85’ (yellow
sticks) results in closure of the channel. The N-terminal domain is shown in cyan, the catalytic domain in
gray, and the C-terminal domain in magenta, while the opposite monomer is shown in yellow. The image
was created by aligning the A and B monomers of PDB file 2BWN with those of 2BWO using PyMOL.

Figure 3.2. The side chain of N85’ becomes reoriented during the closed (cyan) to open (gray)
conformational transition in R. capsulatus ALAS. Only in the closed conformation does N85’ form an
H-bond with Q359 of the flexible active site loop. N85’ in R. capsulatus ALAS corresponds to N150’ in
mALAS2. The image was created by aligning the A and B monomers of PDB file 2BWN with those of
2BWO using PyMOL.
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Materials and methods
Reagents
The following reagents were obtained from Fisher Scientific: glycine, potassium
phosphate monobasic, potassium phosphate dibasic, HEPES, glycerol, and sodium hydroxide. A
bicinchoninic acid assay kit was from Thermo Scientific. 5-Aminolevulinate hydrochloride was
from Acros Organics, and pyridoxal 5’-phosphate, bovine serum albumin (BSA) standards,
DEAE resin, and ACA-44 ultrogel were from Sigma-Aldrich.

Construction and isolation of the N150H variant
The N150H variant was obtained by screening a library of mALAS2 variants for ALAS
activity as described previously for the T148A variant (11).

Overproduction and purification of wild-type mALAS2 and variant enzymes
Wild-type mALAS2 and the variant enzyme were overproduced and purified as
previously described (16). All purification steps subsequent to cell lysis were performed in one
day, and the concentrated proteins were stored under liquid nitrogen for further use. Protein
purity was assessed by SDS-PAGE, and all enzymes were purified to homogeneity. The protein
concentration of the enzymes used for steady-state kinetic analyses was determined by the
bicinchoninic acid-based assay using BSA as standard and measuring the absorbance of each
sample and standard at 532 nm after incubation at 37 ºC for 30 minutes as described in the
protocol supplemented by the manufacturer (thermo scientific). Protein concentration of
enzymes used in pre-steady state kinetic analyses was determined spectroscopically from the
absorbance at 280 nm and using an extinction coefficient of 42860 M-1·cm-1 based on the
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mALAS2 amino acid sequence. All protein concentrations are reported according to a subunit
molecular mass of 56,000 Da.

Steady-state kinetics
Steady-state activities of the wild-type mALAS2 and N150H enzymes were determined
using a continuous spectrophotometric assay (17). All assays were performed in 20 mM HEPES,
pH 7.5, containing 10 % glycerol and at 37 ºC and monitored with a Shimadzu UV-2401 PC
spectrophotometer. The pertinent final concentrations in the assays were 2 µM enzyme (wildtype mALAS2 or variant), 5-200 mM glycine and 0.5-20 M succinyl-CoA. The steady-state
kinetic parameters (kcat and Km) were calculated by fitting the data, collected as matrixes of five
glycine and five succinyl-CoA concentrations, to the Michaelis-Menten equation (Eq. 3.1) using
non-linear regression analysis (Sigma-plot software).
Eq. 3.1

Equilibrium dissociation constants for succinyl-CoA and CoA
Equilibrium dissociation constants for succinyl-CoA or CoA were determined by titrating
each of the enzymes (wild-type or N150H) with increasing concentrations of ligand and
monitoring the quenching of intrinsic fluorescence at 340 nm upon excitation at 280 nm. The
titration experiments were performed at 37 ºC and pH 7.5 and monitored using a Shimadzu
RF5301 PC spectrofluorophotometer. Briefly, 1 µM of enzyme in 20 mM HEPES, pH 7.5,
containing 10 % glycerol, was titrated with small aliquots of increasing concentrations of
succinyl-CoA or CoA (from a 24 mM stock) while stirring, until no further change in
fluorescence emission was observed. The addition of ligand did not result in significant changes
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in the reaction volume (~4 % change in the final volume) and it did not affect the pH of the
buffer. The protein and ligands were equilibrated within the cell for 1 minute prior to collecting
the spectra. In order to obtain the fraction of ligand bound (F.B) to the enzyme, data were
normalized using equation 3.2,
F. B.

Eq. 3.2

where x represents the maximal fluorescence emission at specific ligand concentration, xi is the
emission in the absence of ligands, and xf is the emission at the highest concentration of ligand
when the enzyme was fully saturated. The equilibrium dissociation constant, Kd, was determined
by fitting the data to equation 3.3, using SigmaPlot software for the non-linear regression
analyses.
Eq. 3.3

Pre-steady state kinetics
Reactions between the enzyme (mALAS2 or variant)-glycine complex and succinyl-CoA
were analyzed using transient kinetics. Upon rapid mixing of the enzyme-glycine complex with
succinyl-CoA, single-wavelength spectra were collected at 510 nm on a KinTek stopped-flow
spectrophotometer (model SF-2001). All reactions were performed at 18 ºC using a buffer
composed of 50 mM phosphate, pH 7.5 (37 mM K2HPO4/13 mM KH2PO4) and 10 % glycerol
(v/v). For reactions under single turnover conditions, with the enzyme molar concentration in
excess over that of succinyl-CoA, one of the syringes contained 120 µM enzyme (either wildtype mALAS2 or variant) and 200 mM glycine in the above described buffer, while the other
syringe contained 40 µM succinyl-CoA in the same buffer. The concentrations of reactants in the
observation cell were one-half of those in the syringes. For reactions conducted under multiple
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turnover conditions, with succinyl-CoA in excess over enzyme, one of the syringes contained 60
µM enzyme (either wild-type mALAS2 or variant) and 200 mM glycine in the above phosphate
buffer, whereas the other syringe contained excess succinyl-CoA in the same buffer. Using the
KinTek stopped-flow software, the time course data were fitted to either a two- or threeexponential equation (Eq. 3.4),

Eq. 3.4
where At is the absorbance at time t, a is the amplitude of each phase, k is the observed rate
constant for each phase and c is the final absorbance. The reaction between wild-type mALAS2
or variant enzyme and ALA was also examined using transients by monitoring the change in
absorbance at 510 nm upon rapid mixing of the reactants. One of the syringes contained 60 µM
enzyme in the above 50 mM phosphate buffer, while the other syringe contained ALA in the
same buffer. Prior to reacting mALAS2 (or the N150H variant) with ALA, the ALA-HCl stock
was neutralized in equal molar concentration of NaOH. This was accomplished by creating 2fold serial dilutions of ALA and NaOH, where the final concentration of ALA in the observation
chamber, neutralized in equal molar concentration of NaOH, varied from 0.5 to 30 mM. Once
the reaction was completed, it was verified that the pH in the syringe was 7.5. The dependence of
the observed pseudo-first order rate constants on the concentration of ALA were fitted to an
equation describing a two-step reaction (Eq. 3.5), using non-linear regression analyses (Sigmaplot software).
Eq. 3.5
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Results
Steady-state kinetics and specificity constants
The steady-state kinetic parameters and specificity constants for wild-type mALAS2 and
the N150H variant were determined at 37 °C and pH 7.5 (Table 3.1). The mutation resulted in a
50 % decrease in the kcat value, with no changes in

, and only a modest increase in the

. Interestingly, the kcat reported here for mALAS2 without a His-tag is about ~3-fold lower
than the one reported by Tan et al. (18) under identical conditions for the enzyme with an Nterminal His-tag. However, in that study, the enzyme concentration was estimated using a BCAbased assay after the protein was precipitated with acetone (18, 19). We validated that acetone
precipitation can underestimate the protein concentration (data not shown), and thus, the
disparities in the reported kcat values largely result from differences in the methods used to
quantify the protein concentration, and not from the presence of a His-tag.

Table 3.1
Steady-State Kinetic Parameters and Specificity Constants
Gly
SCoA
Gly
Enzyme
kcat
Km
Km
kcat / K m
-1
(s )
(µM)
(s-1.mM-1)
(mM)
wt mALAS2
0.19±0.01
18±3
1.3±0.3
11 x10-3±2 x10-3
N150H
0.09±0.002
32±4
1.2±0.2
2.8 x10-3±0.4 x10-3

SCoA

kcat / K m
(s-1.µM-1)
146 x10-3±41 x10-3
75 x10-3±14 x10-3

Equilibrium dissociation constants for succinyl-CoA and CoA
The equilibrium dissociation constant (Kd) values for succinyl-CoA and CoA were
determined at 37 °C and pH 7.5 by monitoring the quenching in intrinsic protein fluorescence
upon titration of the wild-type enzyme or the N150H variant with increasing concentrations of
ligand (Fig. 3.3). Wild-type mALAS2 exhibited equal binding affinity toward succinyl-CoA and
CoA, implying that binding is primarily facilitated by the CoA moiety (Table 3.2). Moreover, the
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wild-type and N150H enzymes have identical KdSCoA values within error, while the N150H
variant displayed weaker binding toward CoA (Table 3.2). Since CoA lacks a succinyl moiety,
the results suggest an important role for the succinyl moiety in the binding of succinyl-CoA to
the active site of the N150H variant. Interestingly, there are notable differences between the Km
and Kd values for succinyl-CoA (Tables 3.1 and 3.2). For the wild-type enzyme, the Kd value is
about 230-fold greater than the Km value. These findings imply that KmSCoA does not represent a
measure of substrate affinity analogous to the k-1/k1 term, which describes the Kd (with k-1 and k1
representing the rate constants associated with the dissociation and association of succinyl-CoA
to mALAS2, respectively), but rather it represents a complex kinetic function of all the rate
constants in the pathway.

Figure 3.3. Binding isotherms for the association of succinyl-CoA or CoA with wild type mALAS2
or the N150H variant enzyme. Titration of (A) wild-type mALAS2 and (B) N150H with increasing
concentration of succinyl-CoA; titration of (C) wild-type mALAS2 and (D) N150H with increasing
concentrations of CoA. All reactions were done in duplicates and the error bars are covered with the
symbols.
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Table 3.2
Equilibrium dissociation constants for Succinyl-CoA
and CoA
Enzyme
µM
µM
wt mALAS2
297 ± 7
302 ± 12
N150H
281 ± 7
495 ± 25

Single-turnover experiments
Pre-steady state reactions between the enzyme-glycine complex and succinyl-CoA were
conducted under single turnover conditions, with enzyme concentrations in excess over those of
succinyl-CoA, and followed by monitoring the changes in absorbance at 510 nm that result from
the formation of the quinonoid intermediate II (Fig. 3.4, [Scheme 3.1, VII]). Because of the rapid
formation and transient nature of the quinonoid intermediate II, it was challenging to accurately
discern the individual kinetic phases at 37 °C, and consequently, the reaction was monitored at
18 °C and pH 7.5. The reactions for either the wild-type or variant enzymes are best described by
a three-exponential process (Fig. 3.4). Previous extensive single-turnover experiments with
mALAS2 have led to the assignment of the three kinetic steps to 1) generation of the quinonoid
intermediate II upon decarboxylation of the 2-amino-3-ketoadipate intermediate, 2) decay of this
quinonoid intermediate, as facilitated by protonation of the enol by K313, and 3) conformational
rearrangement of the enzyme to induce ALA release from the active site (Scheme 3.1) (7).
Presented in table 3.3 are the three observed rate constants for the reactions catalyzed by the
wild-type and variant enzymes. A significant decrease in the rate of formation of the quinonoid
intermediate II was detected for the N150H-catalyzed reaction, with an observed rate constant
k1 = 0.81 ± 0.02 s-1. This rate is by 79 % lower than that of the wild-type enzyme, while
decreases of 73 % and 47 % were detected for the rates of quinonoid decay (k2) and ALA release
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(k3), respectively (Table 3.3). These data implicate an important role for N150 in catalysis,
probably by stabilizing the positioning of the condensation intermediate in an orientation that is
favorable for decarboxylation.

Figure 3.4. Kinetic traces of the reactions of enzyme (wild-type mALAS2 or N150H)-glycine
complex with succinyl-CoA under single turnover conditions. The kinetic traces for the reactions of
(A) wild-type mALAS2-glycine and (B) N150H-glycine complexes with 20 µM succinyl-CoA (purple
circles), as followed by monitoring the changes in the quinonoid intermediate absorbance at 510 nm, were
overlaid with the lines (black) calculated from the data fitting to equation 3.4 for a three-exponential
process. The reported succinyl-CoA concentration is that in the observation chamber.

Table 3.3
Observed rate constants for the reaction between the enzyme-glycine complex
and succinyl-CoA
Enzyme
k1
k2
k3
s-1
s-1
s-1
wt mALAS2
3.8 ± 0.03
0.59 ± 0.005
0.038 ± 0.001
N150H
0.81± 0.02
0.16 ± 0.002
0.020 ± 0.001
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Multiple turnover experiments
The transient reaction between the enzyme-glycine complex and succinyl-CoA,
monitored by following the absorbance changes at 510 nm, was also conducted under multiple
turnover conditions (18 °C and pH 7.5), with succinyl-CoA concentration in excess over those of
the enzyme. While the reactions catalyzed by the wild-type enzyme were best described by a
biphasic process, corresponding to the formation of the quinonoid intermediate II followed by its
steep decay into the steady-state (Fig. 3.5A-C), the progress curves of the N150H variantcatalyzed reactions displayed an apparent, prolonged decay of the quinonoid intermediate II into
the steady-state (Fig. 3.5D-F). This precluded us from fitting the data for the N150H-catalyzed
reactions to a two-exponential equation, without significant residual error (data not shown).
Lowering the succinyl-CoA concentration in the N150H-catalyzed reaction resulted in a more
rapid decay of the quinonoid intermediate II, implying a potential accumulation of reaction
intermediates absorbing at the wavelength of interest (Fig. 3.5). Of note, in some reactions (see
Fig. 3.5 legend), we violated the multi-turnover premise by lowering the succinyl-CoA
concentration to 30 μM with the aim of showing that the decay of the kinetic trace displayed
dependence on the concentration of succinyl-CoA.

Reaction of ALA with either wild-type mALAS2 or N150H
Since the kinetic trace for the multi-turnover reaction of the N150H-glycine complex
with succinyl-CoA revealed a prolonged decay of the quinonoid intermediate II into the steadystate (Fig. 3.5), which may have resulted from accumulation and transformation of ALA back
into the quinonoid intermediate II (Scheme 3.1), we set to examine the mALAS2- and N150Hcatalyzed reverse reactions. Previously, we demonstrated that binding of ALA to ALAS is
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followed by the formation of a stable quinonoid intermediate (Scheme 3.1, VII) with a
characteristic absorbance maximum at 510 nm (5, 6). Thus, the reverse-catalyzed reactions
leading to the quinonoid intermediate II production were examined after reacting ALA with
either wild-type mALAS2 or N150H, at 18 °C and pH 7.5, by monitoring the absorbance at 510
nm with stopped-flow spectroscopy. A biphasic process describes the time courses for either of
the two enzyme reactions with ALA (Fig. 3.6A and B). In agreement with previous studies (5,
6), the observed rate for the second and slow phase of the wild-type mALAS2 reaction was
independent of the ALA concentration, while the fast phase rate displayed a hyperbolic
dependence on ALA concentration (Fig. 3.6C).

Figure 3.5. Kinetic traces of the reactions of enzyme (wild-type mALAS2 or N150H)-glycine
complex with succinyl-CoA under multiple turnover conditions. Progress curves, as monitored from
the changes in absorbance at 510 nm, were collected for the reactions between the wild-type mALAS2glycine complex and (A) 30 µM, (B) 80 µM, and (C) 160 µM succinyl-CoA, and for the N150H-glycine
complex reacted with (D) 30 µM, (E) 80 µM, (F) and 160 µM of succinyl-CoA. The reported
concentrations of succinyl-CoA are those present in the observation chamber. In A-C, once the
absorbance reached a plateau, there were no fluctuations for the initial 70s (not shown). Where applicable,
(A-C), the data were fitted to a two-step exponential equation, and data points (purple) are overlaid with
the fitted line (black).
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Fitting of the data for the ALA-dependent fast phase rates to equation 3.5 yielded a kon value of
0.61 ± 0.01 s-1 (Fig. 3.6C). Similarly to the wild-type mALAS2-catalyzed reaction, the observed
rate for the fast phase of the N150H with ALA reaction reached a plateau with increasing ALA
concentrations, and the slow phase rate was ALA concentration-independent (Fig. 3.6D).
Importantly, kon of 1.39±0.07 s-1 was obtained for the fast phase of the N150H catalyzed
formation of the ALA-quinonoid intermediate, indicating 57 % increase in the reaction rate
relative to the wild-type enzyme. Interestingly, from the kinetic data fit, we have obtained
=4.7±1.3 mM for the N150H variant, which is higher than the

=2.5±0.2 mM for the

wild-type enzyme. This indicates less tighter binding of ALA to N150H; however, once bound to
the active site, the rate for the catalytic transformation of ALA into the quinonoid intermediate is
increased, possibly by providing active site environment that favors catalysis with ALA and/or
slowing the release of ALA from the active site.

Discussion
The physiological importance for catalytic precision in the rate of ALA synthesis
becomes obvious if we consider the overwhelming demand of developing erythroid cells for
heme during hemoglobinization and their requirement to avert perturbations in porphyrin and
iron metabolism that can lead to cellular toxicity. In fact, even subtle disturbances in the rate of
ALA synthesis, due to either loss-of-function or gain-of-function mutations in the ALAS2 gene,
result in erythropoietic disorders, such as XLSA and XLDPP (3, 4). Therefore, the necessity to
evolve away from hypoactivity and hyperactivity must have been a defining evolutionary
pressure in shaping the active site of ALAS2. Besides the critical need to synthesize ALA at a
physiologically relevant rate, it can be argued that equally important evolutionary necessities,
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albeit quite overlooked, were for ALAS to minimize the non-productive transformation of ALA
and establish a catalytic balance between the forward and reverse reactions. The combination of
these factors has probably made possible for differentiating erythroid cells to utilize ALA
predominantly for heme biosynthesis. However, regions of the active site contributing to the
achievement of this catalytic balance have never been identified prior to this study.

Figure 3.6. Reactions of wild-type mALAS2 or N150H variant with ALA. Progress curves for the
reactions of 15 mM ALA with (A) wild-type mALAS2 (30 µM), or (B) the N150H variant (30 µM) were
collected by monitoring the change in absorbance at 510 nm. The data were fitted to a two-exponential
equation, and the data points (purple) are overlaid with the fitted lines (black). (C) The observed rates for
the slow phase (filled circles) of the wild-type mALAS2 reaction displayed no dependence on the
concentration of ALA, while the observed rates for the fast phase (clear circles) exhibited a hyperbolic
dependence on ALA, yielding kon = 0.61 ± 0.01 s-1; koff = 0.16 ± 0.01 s-1;
= 2.5 ± 0.2 mM. (D)
Similarly, upon reaction with ALA, the slow phase (filled circles) for the N150H reaction displayed no
dependence on ALA concentration, while the fast phase (clear circles) exhibited hyperbolic dependence,
= 4.7±1.3 mM. All reactions shown in C and D
resulting in kon= 1.39 ± 0.07 s-1; koff= 0.03 ± 0.07 s-1;
were done in triplicates, and the error bars are shown beneath the symbols.
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Structural analysis of R. capsulatus ALAS revealed essential roles for N85 (N150 of
mALAS2) in both gating the alternative active site channel (Fig. 3.1), and coordinating the
positioning of succinyl-CoA and the condensation intermediate. Based on these observations, we
have examined the role of mALAS2 N150 in catalysis by substituting this amino acid with a
histidine and performing detailed kinetic and equilibrium studies. Comparison of the steady-state
kinetic parameters for the N150H variant with those for the wild-type enzyme indicated that the
mutation resulted in a 50% decrease in the kcat value (Table 3.1). Even though N150 coordinates
the positioning of succinyl-CoA, no changes in the

value were detected with the N150H

mutation. Moreover, the binding affinity toward succinyl-CoA was not perturbed by this
mutation, since the Kd value of the variant was identical with that of wild-type mALAS2 (Table
3.2). However, the binding of CoA to the variant was weaker than to wild-type mALAS2,
although in the absence of structural information, it is difficult to rationalize how the N150H
mutation weakens the affinity, particularly since N150 interacts with the succinyl rather than the
CoA moiety. It is possible that the mutation indirectly disturbs the integrity of the CoA binding
site. Interestingly, the binding of succinyl-CoA to the wild-type enzyme is primarily facilitated
by the CoA, not the succinyl-moiety, as evident from the identical Kd values for succinyl-CoA
and CoA (Table 3.2.).
Our study further revealed that the equilibrium dissociation constant,

, which

reflects the binding affinity of the enzyme toward succinyl-CoA, differs significantly from the
Michaelis constant,

— a constant that describes the ligand concentration at which V

equals ½ Vmax. The Michaelis constant is often misinterpreted for the dissociation constant,
although the two constants may, or more likely, may not be equal to each other (20). In the case
of wild-type ALAS, the

value is about 230-fold greater than the
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(Tables 3.1 and

3.2). These data indicate that

does not represent a measure of substrate affinity analogous

to the k-1/k1 term, which describes the Kd, but rather it represents a complex, kinetic function of
multiple rate constants in the pathway. The complexity of the Km expression of a reaction
pathway containing a single intermediate—which is far less complicated than the multiintermediate pathway of the ALAS mechanism—has been reported elsewhere (20).
The significant reductions in the observed pre-steady state rates for the formation (k1) and
decay (k2) of the quinonoid intermediate II (Scheme 3.1, VII) that ensued when N150 was
substituted with a histidine strongly implicate a key role for this asparagine in catalysis. In
comparison to the wild-type enzyme, the N150H-catalyzed reaction between glycine and
succinyl-CoA, examined during a single turnover, resulted in reductions by 79 % and 73 % in the
rates of formation and decay of the quinonoid intermediate II, respectively (Table 3.3). Since
N150 is predicted to interact with the succinyl-derived carboxyl group of the condensation
intermediate (the 2-amino-3-ketoadipate intermediate [Scheme 3.1, V], which is a precursor of
the quinonoid intermediate II [Scheme 3.1, VII]), it is plausible that the N150H mutation affects
the attainment of a catalytically optimal orientation between this intermediate and reactive
centers, thus resulting in a higher energetic barrier associated with its transformation into the
quinonoid intermediate II.
When the formation of the quinonoid intermediate for the N150H catalyzed reaction
between glycine and succinyl-CoA was examined during multiple turnovers, prolonged decay of
the quinonoid intermediate into the steady state was observed, which could not be detected for
the reaction catalyzed by the wild-type enzyme (Fig. 3.5). This prolonged decay of the quinonoid
intermediate was dependent on the concentration of succinyl-CoA, suggesting potential
accumulation of other reaction intermediates that absorb at the monitored wavelength. Since in
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the reverse reaction, upon reacting with the product, ALA, the enzyme catalyzes the formation of
a stable quinonoid intermediate with an absorbance maximum at 510 nm, we examined the rates
associated with the formation of this intermediate, and kon=1.39±0.07 s-1 was obtained for the
fast phase of the N150H catalyzed reaction. This rate constant is by 59 % increased than that of
the wild-type enzyme (kon=0.61±0.01s-1), indicating that the N150H mutation promotes an
accelerated transformation of ALA into the quinonoid intermediate.
Significantly, our results imply that N150 is essential in establishing catalytic balance
between the forward and reverse reactions of mALAS2 by favoring formation of ALA over its
non-productive transformation into the quinonoid intermediate. We arrived to this conclusion
based on the differences that were detected in the rates of quinonoid intermediate formation
during the forward (i.e., with glycine and succinyl-CoA) and reverse (i.e., with ALA) reactions
catalyzed by the N150H and wild-type enzymes. In fact, relative to the rate of quinonoid
intermediate II catalysis in the forward reaction (k1=0.81±0.02 s-1), the N150H variant transforms
ALA into the quinonoid intermediate at a rate that is 1.7-fold higher (kon=1.39±0.07 s-1). In
contrast, the magnitude of these rates for the wild-type reactions is strikingly different. The
difference is such that relative to the rate of quinonoid intermediate II catalysis in the forward
reaction (k1=3.8±0.03 s-1), in the reverse reaction, wild-type mALAS2 transforms ALA into the
quinonoid intermediate at a rate that is 6.3-fold lower (kon=0.61±0.01s-1).
These imbalances in the rates, where the N150H reaction with ALA is accelerated over
that with glycine and succinyl-CoA, can account for the apparent, prolonged decay of the
quinonoid intermediate into the steady-state that was detected during multiple turnovers (Fig.
3.5), implicating that the N150H variant preferentially catalyzes transformation of ALA into the
quinonoid intermediate over initiating another round of catalysis with its substrates. Therefore, it
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is evident that evolutionary pressure favored the selection of this invariant asparagine in order to
endow ALAS with improved catalytic specificity toward the reaction with glycine and succinylCoA. It is possible that during some evolutionary stage, besides the obvious positive selective
pressure from the substrates, negative selective pressure by ALA also contributed in shaping the
active site architecture of ALAS, leading to the selection of N150, which in turn was important
in minimizing reactivity with ALA. This lack of reactivity was necessary to ensure that ALA is
utilized predominantly for heme biosynthesis rather than for glycine and succinyl-CoA
production. Moreover, T148 (mALAS2 numbering), which is also part of the glycine-rich stretch
where N150 is located, was shown to be essential for the specificity of ALAS toward the amino
acid substrate (11-13), further corroborating the importance of this structural region in defining
the reaction selectivity.
The crystal structure of R. capsulatus ALAS indicates that the asparagine (N85’)
analogous to N150’ of mALAS2 associates with Q359 of the flexible active site loop in the
closed conformation (Fig. 3.2). During reversion to the open conformation, the interaction is
disrupted, and the side chain of the asparagine becomes reoriented away from the loop, leading
to opening of the alternative side channel (Figs. 3.1 and 3.2). Since this asparagine plays an
important role in the reversion of the enzyme to the open conformation and in effective opening
of the alternative channel, it is plausible that the N150H mutation interferes with the release of
ALA from the active site, resulting in the accumulation and transformation of ALA into the
quinonoid intermediate. An alternative, and not mutually exclusive, possibility for the increased
reactivity with ALA is that, in comparison to wild-type mALAS2, the active site of N150H
provides a catalytic environment that lowers the energetic barrier required for the chemical
transformation of ALA into the quinonoid intermediate.
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Chapter Four
Catalytically active alkaline molten globular enzyme: Effect of pH and temperature on the
structural integrity of 5-aminolevulinate synthase3
Abstract
5-Aminolevulinate synthase (ALAS), a pyridoxal-5’phosphate (PLP)-dependent enzyme,
catalyzes the first step of heme biosynthesis in mammals. Circular dichroism (CD) and
fluorescence spectroscopies were used to examine the effects of pH (1.0-3.0 and 7.5-10.5) and
temperature (20 and 37 °C) on the structural integrity of ALAS. The secondary structure, as
deduced from far-UV CD, is mostly resilient to pH and temperature changes. Partial unfolding
was observed at pH 2.0, but further decreasing pH resulted in acid-induced refolding of the
secondary structure to nearly native levels. The tertiary structure rigidity, monitored by near-UV
CD, is lost under acidic and specific alkaline conditions (pH 10.5 and pH 9.5/37 °C), where
ALAS populates a molten globule state. As the enzyme becomes less structured with increased
alkalinity, the chiral environment of the internal aldimine is also modified, with a shift from a
420 nm to 330 nm dichroic band. Under acidic conditions, the PLP cofactor dissociates from
ALAS. Reaction with 8-anilino-1-naphtalenesulfonic acid corroborates increased exposure of
hydrophobic clusters in the alkaline and acidic molten globules, although the reaction is more
pronounced with the latter. Furthermore, quenching the intrinsic fluorescence of ALAS with
acrylamide at pH 1.0 and 9.5 yielded subtly different dynamic quenching constants. The alkaline

3

Note to reader. This research was originally published in Biochimica et Biophysica Acta Proteins and Proteomics
(1). (Stojanovski et al. Biochim. Biophys. Acta, 2014, 1844:2145-2154). Reprinted here with permission from
Elsevier (See Appendix 2).
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molten globule state of ALAS is catalytically active (pH 9.5/37 °C), although the kcat value is
significantly decreased. Finally, the binding of 5-aminolevulinate restricts conformational
fluctuations in the alkaline molten globule. Overall, our findings prove how the structural
plasticity

of

ALAS

contributes

to

reaching

a

functional

enzyme.

Introduction
5-Aminolevulinate synthase (ALAS) catalyzes the condensation between glycine and
succinyl-CoA to generate CoA, CO2, and ALA (1-3). This reaction represents the first, and
regulated, step of heme biosynthesis in mammals, and subtle disturbances in the rate of ALA
formation resulting from either loss-of-function or gain-of-function mutations in the human
erythroid specific gene, ALAS2, can lead to X-linked sideroblastic anemia and X-linked
dominant protoporphyria, respectively (4, 5).
Murine erythroid ALAS (henceforth abbreviated as mALAS2) is a homodimer with a
molecular weight of 112 KDa (6). Each of its two active sites is located at the dimeric interface,
and is composed of amino acids from the individual monomers (7). Pyridoxal 5’-phosphate
(PLP), which serves as a cofactor during catalysis, is covalently attached to an active site lysine
(K313 in mALAS2), forming an internal aldimine (8). The absorbance spectrum of mALAS2 in
the absence of substrates displays maxima at 330 and 420 nm, representing different tautomeric
species of the internal aldimine (Fig. 1.1) (9). Previously, we assigned the 420 nm-absorbance
maximum to a ketoenamine species, and we utilized fluorescence spectroscopy to assign the 330
nm maximum to a substituted aldamine (9). Moreover, positive dichroic bands with maxima at
approximately 330 and 420 nm are detected in the circular dichroism (CD) spectrum of
mALAS2 (10, 11), and since PLP by itself is not a chiral molecule (11), the two maxima indicate

86

an equilibrium between two populations of internal aldimine species with different chiral active
site environments.
The catalytic activity of mALAS2, monitored under steady and pre-steady state
conditions, exhibits dependence on pH (9, 12). Specifically, an increase in alkalinity is
accompanied by a decrease in the kcat value (9) and a decrease in the pre-steady state rate
formation of the second quinonoid intermediate (12). Temperature also affects the catalytic
turnover of mALAS2. In fact, when the temperature changes from 20 to 37 °C, the kcat value is
increased by 30-fold, as determined using a continuous, coupled, enzymatic assay (13). The
temperature at which 50% of the enzymatic activity of mALAS2 is lost was determined to be
55.3 °C (14). Thus far, however, it is not known to what extent pH and temperature affect the
structural integrity of ALAS.
The crystal structure of Rhodobacter capsulatus ALAS (Fig. 4.1) reveals significant
content of α-helices and β-sheets that fold into three separate and well-defined domains, which
constitute the tertiary structure of each monomer (15). Two different conformations have been
observed: open and closed, where the active site of the former conformation is exposed to the
solvent, while in the latter, the active site is partly protected as a result of segmental, structural
rearrangements (15). Importantly, both conformations were observed in the native state of the
holoenzyme (15), suggesting that even in the absence of substrates, interconversion between the
conformations occurs; however, based on kinetic data, it was inferred that the binding of
succinyl-CoA accelerates the transition of ALAS to the catalytically competent closed
conformation (16, 17). Conformational interconversion also dominates the kcat, and the rate
limiting step of the reaction had been assigned to a transition from the closed to the open
conformation during dissociation of ALA from the active site (16, 17).
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Figure 4.1. Crystal structure of R. capsulatus ALAS. The distribution of color indicates: in pink, amino
acids with ionizable side groups whose theoretical pKa is lower than 5 (i.e., Asp and Glu); in cyan, amino
acids with ionizable side groups whose theoretical pKa is greater than 5 (i.e., His, Cys, Tyr, Lys, and Arg);
in yellow, amino acids with hydrophobic side chains (i.e., Ala, Val, Leu, Ile, Trp, Phe, and Met) and in
white, all other amino acids (i.e., Ser, Thr, Asn, Gln, Pro, and Gly) [PDB 2BWO].

Therefore, it is evident that a certain level of structural plasticity is important for effective
catalysis. Yet the question remains to what extent can the structural integrity of ALAS deviate
from its native state without compromising the catalytic activity. Several enzymes have been
shown to retain catalytic activity (18-21), even though they assume a partially folded, molten
globule state: a highly dynamic conformational ensemble, where due to absence of close packing
in the protein core, the rigidity of the tertiary structure is lost, without significant disruption in
secondary structure content (22). To our knowledge the list of enzymes includes: circularly
permuted dihydrofolate reductase (18), double point mutant of nuclease (19), UreG (20), and
monomeric chorismate mutase (21). Among the aforementioned enzymes, monomeric
chorismate mutase (21) is of particular interest, because this “molten globule” enzyme, whose
structure becomes ordered upon ligand binding, retains identical catalytic activity as that of
natively folded, dimeric chorismate mutase (21). This indicates that catalytic turnover in some
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enzymes may remain unperturbed even when the rigidity of the tertiary structure in the absence
of ligands is disrupted.
In this study we have examined how pH and temperature affect the structural integrity of
mALAS2. While the integrity of the secondary structure is resilient to fluctuations in pH and
temperature within the examined range, the rigidity of the tertiary structure is disrupted under
specific alkaline and acidic conditions and the enzyme exists in a molten globule state. These
structural changes proceed with concomitant modification in the chiral active site environment of
the internal aldimine. Finally, we show that the enzyme retains catalytic activity, albeit reduced,
in the alkaline molten globule state, as previously and experimentally defined in the absence of
ligands. To the best of our knowledge, this is the first reported case of a catalytically active
alkaline molten globular enzyme.

Materials and methods
Reagents
Acrylamide, potassium phosphate monobasic, potassium phosphate dibasic, Tris, glycine,
acetylacetone, and sodium acetate trihydrate were purchased from Fisher. PLP, 8-anilino-1naphtalenesulfonic acid (ANS), p-dimethylaminobenzaldehyde, and CAPS were from SigmaAldrich. AMPSO was from MP Biomedicals, and trichloroacetic acid (TCA) and 5aminolevulinate hydrochloride were from Acros Organics.

Overproduction and purification of wild-type mALAS2
Wild-type mALAS2 was overproduced and purified as described previously (6). All
purification steps were performed in one day and the purity of the protein was assessed by SDS-
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PAGE. The purified enzyme was concentrated to 12 mg/mL using an Amicon cell with a 30000
MW cut-off membrane and then dialyzed against 2 L of 50 mM phosphate, pH 7.5, containing
40 µM PLP. The protein was stored under liquid nitrogen for further use. The monomeric protein
concentration was determined spectroscopically using an extinction coefficient of 42860 M-1 cm1

calculated from its amino acid sequence.

Circular dichroism measurements
CD measurements were collected using a JASCO J-815 spectropolarimeter and a scan
speed of 20 nm/min at either 20 or 37 ºC. The temperature was regulated using a thermostatically
controlled cell holder. For the measurements collected in the far-UV region (260-190 nm), the
concentration of protein was 0.15 mg/ml and a cell with a 0.1 cm path length was used. The
measurements were conducted at different pH values using the following buffers: 20 mM
KH2PO4, pH 1.0, 20 mM KH2PO4, pH 2.0, 20 mM citrate, pH 3.0 (16.7 mM citrate dihydrate and
3.3 mM sodium citrate dihydrate), 20 mM phosphate, pH 7.5 (16 mM K2HPO4 and 4 mM
KH2PO4), 20 mM TRIS, pH 8.5, 20 mM AMPSO, pH 9.5 and 20 mM CAPS, pH 10.5. The pH
of the buffers was adjusted either with hydrochloric acid or sodium hydroxide. Each reported
measurement in the far-UV region represents the average of four accumulated spectra.
Protein concentration of 1 mg/mL and a cell with a 1 cm path length was used for the
measurements in the near-UV / visible region (500-260 nm), which were conducted in identical
buffers as those used for the measurements in the far-UV region. The total volume in the cell was
2.5 mL, and once the measurements were completed, the pH was immediately verified using an
Accumet AR15 pH meter to ensure that the pH of the buffer did not change as a result of the
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addition of protein. Each of the reported measurements in the near-UV / visible range represents
the average of three accumulated spectra.
CD spectra in the near-UV/visible range (500-260 nm) were collected in the presence or
absence of ALA at pH 9.5 and 37 °C. The experiments were performed in 50 mM AMPSO
buffer, pH 9.5, with ALAS and ALA concentrations of 1 mg/mL and 4 mM, respectively. In
order to prevent changes in the buffer pH as a result of the high acidity of ALA, 4 mM ALA
(from 0.5 M stock) was neutralized with equal volume of 1 M NaOH prior to initiating the
reaction. The pH of the buffer, measured after adding 4 mM ALA to the enzyme, was 9.5.

Reaction with ANS
Fluorescence spectra for the reaction between ANS and wild-type mALAS2 were
collected using a Shimadzu RF 5301PC spectrofluorophotometer. All experiments were
performed at either 20 or 37 ºC and the following pH values: 1, 2, 3, 7.5, 8.5, 9.5, and 10.5.
Identical buffers were used as those described in the circular dichroism measurement section.
Due to the low solubility of ANS in water, stock solution of 50 mM ANS was initially prepared
in dimethyl sulfoxide (DMSO), which was further diluted in deionized water to prepare a stock
of 4 mM ANS. Reactions at the pH value of interest were performed by incubating 1 µM wildtype mALAS2 (0.06 mg/mL), 20 µM ANS, and 20 mM buffer for 1 hour at either 20 or 37 ºC.
As negative controls, reactions at the pH value of interest were performed in the absence of
protein by incubating 20 µM ANS and 20 mM buffer for 1 hour at either 20 or 37 ºC.
Fluorescence spectra were then collected at either 20 or 37 ºC by monitoring the emission in the
400-600 nm range, following excitation at 375 nm. A cell with a 0.3 cm path length was used

91

and the temperature in the cell holder was regulated using a circulating water bath. All reactions
were performed in triplicates.

Acrylamide quenching of intrinsic protein fluorescence
The accessibility of tryptophans in wild-type mALAS2 was examined by monitoring the
fluorescence spectra resulting from the quenching of the intrinsic fluorescence of the enzyme
upon reaction with acrylamide. All reactions were conducted at either 20 or 37 ºC and the
following pH values: 1, 7.5, and 9.5. The buffers used were: 20 mM KH2PO4, pH 1; 20 mM
phosphate, pH 7.5 (16 mM K2HPO4 and 4 mM KH2PO4); 20 mM AMPSO, pH 9.5. Reactions at
the pH value of interest were performed by incubating 1 µM wild-type mALAS2 (0.06 mg/mL),
acrylamide, and 20 mM buffer for 5 minutes at either 20 or 37 ºC. To ensure that the pH of the
reaction was not modified by the addition of acrylamide, 2 M acrylamide stock solution was
prepared in the following buffers: 20 mM KH2PO4, pH 1.0; 20 mM phosphate, pH 7.5 (16 mM
K2HPO4 and 4 mM KH2PO4); 20 mM AMPSO, pH 9.5. Fluorescence spectra were collected on a
Shimadzu RF 5301PC spectrofluorophotometer by monitoring the emission at 340 nm upon
excitation at 280 nm. During the collection of the spectra, the temperature in the cell holder was
maintained at either 20 or 37ºC, and a cell with a path length of 0.3 cm was used. All reactions
were performed in triplicates. The data resulting from the quenching of the intrinsic fluorescence
were analyzed using the Stern-Volmer equation (Eq.4.1),
1

Q

Eq. 4.1

where F0 is the fluorescence emission in the absence of acrylamide, F is the emission at a
specific concentration of acrylamide, Ksv is the dynamic quenching constant, and Q is the
concentration of acrylamide.
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Colorimetric assay for determination of ALAS activity
The catalytic activity of wild-type mALAS2 was examined using a colorimetric assay,
which, briefly, involves the quantitation of the ALA-derived pyrrole upon reaction with Ehrlich’s
reagent by monitoring the absorbance at 552 nm (23). All reactions were performed at 37 ºC in
the acidic and alkaline pH ranges. Identical buffers were used as described in the circular
dichroism measurement section, with the exception that the buffer concentration was 100 mM.
Preliminary studies demonstrated that the addition of substrates did not modify the pH value of
the reaction, with the exception at pH 10.5, where the addition of 50 mM glycine lowered the pH
to 10.3 (data not shown). The reaction assay was performed in the following way: 4 µM of wildtype mALAS2 (from a 220 µM mALAS2 stock ) was added to a reaction tube containing 100
mM buffer at the pH of interest, and the sample was equilibrated at 37 ºC for 10 minutes prior to
addition of substrates. Then to each reaction tube, 50 mM glycine (from a 2 M stock of glycine)
and 100 µM succinyl-CoA (from an 8.3 mM stock of succinyl-CoA) were added, and the sample
was immediately returned to the water bath. Incubation for 30 minutes at 37 ºC followed. The
reactions were quenched by adding ½ reaction volume of 50 % TCA to each reaction tube.
Following centrifugation at 12000 x g for 4 minutes at room temperature, aliquots were removed
and placed in separate reaction tubes. Then, final concentration of 3.3 % acetylacetone / 0.3 M
sodium acetate was added and incubation at 80 ºC for 10 minutes followed. The samples were
cooled down to room temperature and equal volume of modified Ehrlich reagent (23) was added.
After incubation for 15 minutes at room temperature, absorbance spectra in the 650-500 nm
region were collected, and from the absorbance at 552 nm, the concentration of ALA was
determined using extinction coefficient of 45 (mmol/L)-1·cm-1. For each reaction performed at a
given pH a negative reaction control was included, where the reaction was quenched prior to the
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addition of substrate by adding ½ reaction volume of 50 % TCA. The negative controls were
subjected to the same colorimetric assay procedure.
To determine the steady-state kinetic parameters of mALAS2, the steady-state activity of
mALAS2 was measured at 37 °C, at either pH 7.5 or 9.5, using the above described colorimetric
assay with slight modifications. The assays were performed by varying the concentration of
succinyl-CoA (0-400 µM) while keeping the concentration of glycine fixed at 200 mM. In
preliminary studies, we established that the pH of the buffer did not change upon addition of
substrates within the range of substrate concentrations used. At physiological pH, the initial
velocities were determined by incubating the wild-type enzyme (4 µM) with both substrates for 1
minute, and then quenching the reaction with ½ reaction volume of 50 % TCA and quantifying
the formation of ALA. For reactions at pH 9.5, which were performed in 250 mM AMPSO
buffer, the initial velocities were determined by incubating the enzyme (4 µM) with the
substrates for a period of 20 minutes followed by quenching of the reaction with acid. The initial
velocities, expressed as the concentration of ALA produced per minute, were plotted against the
concentration of succinyl-CoA, and the data were fitted to the Michaelis-Menten equation (Eq.
4.2) using non-linear regression analysis. Km and kcat values were determined from the fitted data.
All data were analyzed using the program SigmaPlot.
Eq. 4.2

Absorbance spectra of mALAS2 and free PLP at various pH values
The absorbance spectra of wild-type mALAS2 and free PLP in several different buffers
were recorded at 20 °C using a Shimadzu UV-2401 PC spectrophotometer. The buffers were: 50
mM K2HPO4, pH 1.0, 50 mM K2HPO4, pH 2.0, 100 mM citrate, pH 3.0 (83 mM citrate
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dihydrate, 17 mM sodium citrate dihydrate), and 50 mM phosphate, pH 7.5 (40 mM K2HPO4, 10
mM KH2PO4). Spectra were collected immediately upon diluting ALAS in the respective buffer
at intervals of 5 minutes for a time period of 20 minutes. The protein concentration was 40 µM,
while that of free PLP was 50 and 200 µM at physiological and acidic pH, respectively.

Dynamic light scattering
Dynamic light scattering measurements were conducted on a Wyatt DynaPro plate reader
at 25 °C. Wild-type mALAS2 was diluted to a final concentration of 1 mg/ml in the following
buffers: 50 mM K2HPO4, pH 1.0, 50 mM K2HPO4, pH 2.0, 100 mM citrate, pH 3.0, 50 mM
K2HPO4, pH 7.5 and 50 mM AMPSO, pH 9.5. The protein samples and all buffers were filtered
through 0.22 µm filters prior to measurements.

Results
Effects of pH and temperature on the secondary structure of mALAS2
CD spectra in the far-UV region (195-260 nm) were collected to examine how variations
in temperature and pH affect the secondary structure of wild-type mALAS2. At physiological
pH, the far-UV CD spectrum of mALAS2 resembles that of proteins with ordered secondary
structure, and changing the temperature from 20 to 37 ºC has no effect on the secondary structure
(Fig. 4.2). As the pH is lowered to a value of 2.0, the protein becomes progressively disordered;
under these conditions, and in comparison to physiological pH, the 208 nm elliptical minimum is
blue-shifted to 204 nm and the intensity of the 222 nm minimum is decreased (Fig. 4.2A and B).
This trend, however, does not continue with further decreases in pH. In fact, the far-UV CD
spectrum of mALAS2 at pH 1.0 is similar to the spectrum collected at pH 7.5, indicating that the
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secondary structure is restored to near-native levels (Fig. 4.2A and B). Since hydrochloric acid
was used to adjust the pH of the phosphate buffer, and it is present at higher concentrations at pH
1.0 than at pH 2.0, the acid-induced refolding observed in the buffer at pH 1.0 is attributed to the
ability of negative chloride ions to minimize repulsion among positively charged groups of
mALAS2 (see discussion). The integrity of the secondary structure is not significantly modified
by changes in pH in the alkaline range, with only modest effects detected at pH 10.5 (Fig. 4.2C
and D). All far-UV CD spectra were similar at 20 and 37 ºC, indicating that moderate increase in
temperature does not disrupt the secondary structure.

Effects of pH and temperature on the tertiary structure of mALAS2
The effects of pH and temperature on the tertiary structure of mALAS2 were
characterized from the spectra in the near-UV CD region (310-260 nm). As the pH varies from
physiological to alkaline conditions, the rigidity of the tertiary structure is disrupted, as discerned
from the decreased ellipticity in the near-UV signal (Fig. 4.3A and B). The effect is amplified
when the temperature increases from 20 to 37 °C, implying that temperature and alkalinity
enhance conformational mobility and modification in ionic interactions, which significantly
disrupt the tertiary structure of mALAS2 (Fig. 4.3A-D). This can be clearly seen at pH 9.5 upon
increasing the temperature to 37 °C (Fig. 4.3D).
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Figure 4.2. Effects of pH and temperature on the secondary structure of mALAS2. Far-UV CD
spectra collected at (A) acidic pH and 20 °C, (B) acidic pH and 37 °C, (C) alkaline pH and 20 °C, (D)
alkaline pH and 37 °C. The colors of the spectra are: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5
(black), pH 8.5 (red), pH 9.5 (blue), and pH 10.5 (cyan).

Moreover, under alkaline conditions, the actual decrease in the intensity of the near-UV
CD signal is far more pronounced than what it seems in Fig. 4.3. This is because in comparison
to physiological pH, the 330 nm maximum that results from the internal aldimine of ALAS is
profoundly modified in alkaline solution (Fig. 4.4) and thus making the ellipticity at 305 nm
much more intense than that at pH 7.5 (Figs. 4.3 and 4.4). To account for this disparity and
present the actual reduction in elliptical signal more clearly, we have normalized the data by
subtracting the 280 nm ellipticity from that at 305 nm; the normalized data are presented in Fig.
4.5. In the acidic pH range, the CD signal in the near-UV region is at baseline close to zero,
indicating that the enzyme has no rigid tertiary structure (Fig. 4.3). Importantly, the near and farUV CD data indicate that under specific acidic (pH 1 and pH 3) and alkaline (pH 9.5/37 °C and
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pH 10.5) conditions, mALAS2 exists in a molten globule state, where it retains native levels of
secondary structure, without having rigid tertiary structure. At pH 2.0, the enzyme is noticeably
unfolded as it follows from the specific changes in the far-UV CD spectrum.

Figure 4.3. Effects of pH and temperature on the tertiary structure of mALAS2. Near-UV CD
spectra collected at different acidic and alkaline pH values at (A) 20 °C, and (B) 37 °C. (C) Spectra at 20
°C (solid) and 37 °C (dashed) at pH 7.5. (D) Spectra at 20 °C (solid) and 37 °C (dashed) at pH 9.5. The
colors of the spectra are: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5 (black), pH 8.5 (red), pH 9.5
(blue), and pH 10.5 (cyan).
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Figure 4.4. CD spectra of mALAS2 in the 260-350 nm range at (A) 20 °C and (B) 37 °C. The colors
correspond to: pH 7.5 (black), pH 8.5 (red), and pH 9.5 (blue).

Figure 4.5 Dependence of CD ellipticity difference (Δθ280-305) with pH. The CD ellipticity difference
(Δθ280-305) was calculated by subtracting the degree of ellipticity at 280 nm from that at 305 nm. The
symbols correspond to the spectra collected at different temperatures: 20 °C (squares) and 37 °C
(triangles).

Effects of pH and temperature on the PLP-binding site of mALAS2
PLP-dependent enzymes usually display a positive dichroic signal in the 500-310 nm
region of the CD spectrum as a result of the positioning of the internal aldimine in a chiral, active
site environment [(11) and references therein]. At physiological pH value of 7.5, the CD
spectrum of mALAS2 in the 500-310 nm region displays two positive dichroic bands with
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maxima at 430 and 325 nm, where the intensity of the former is more pronounced (Fig. 4.6).
However, as the alkalinity of the solution increases, the chiral environment of the internal
aldimine changes (Fig. 4.6A and B). Starting at pH 8.5, the 325 nm dichroic band becomes more
pronounced than the 430 nm band. This trend continues with further increases in pH and is
accompanied by a shift of the 325 nm maximum toward shorter wavelengths, such that at pH 9.5
the maximum is shifted to 317 nm and to 312 nm at pH 10.5 (Fig. 4.6A and B). In the acidic pH
range (pH 1-3), the CD signal that results from the internal aldimine of mALAS2 is lost,
suggesting severe disruption of the active site environment or dissociation of PLP from the
enzyme (Fig. 4.6C and D). With the exception of the spectra collected at pH 10.5, the spectra
collected at all other pH values were nearly identical at either 20 or 37 ºC (Fig. 4.6).

Figure 4.6. Effects of pH and temperature on the chiral active site environment of the mALAS2
internal aldimine. CD spectra in the 500-310 nm region collected at (A) alkaline pH and 20 °C, (B)
alkaline pH and 37 °C, (C) acidic pH and 20 °C, (D) acidic pH and 37 °C. The colors of the spectra
correspond to: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5 (black), pH 8.5 (red), pH 9.5 (blue), and
pH 10.5 (cyan)
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In order to examine whether PLP remains covalently bound to the active site of ALAS at
acidic pH, the absorbance spectra of mALAS2 were recorded and compared to that of free PLP
(Fig. 4.7). At physiological pH, the absorbance spectrum of free PLP displays a maximum at 390
nm, which differs from the spectrum of ALAS, where, as a result of the Schiff base linkage
between PLP and K313, the maximum is red shifted to 415 nm (Fig. 4.7A). In contrast, PLP does
not bind covalently to the active site lysine of ALAS under acidic conditions. In fact, at acidic
pH, a time-dependent dissociation of PLP from the active site of ALAS was observed. The
spectra of ALAS collected at time point zero and at pH values 1.0-3.0 resembled that of ALAS at
physiological pH; however, within the time period of 20 minutes, the spectra of holo-ALAS
under acidic conditions became similar to the spectra of free PLP in acidic solution, implying
that the cofactor dissociated from the active site (Fig. 4.7B-D). No significant changes in the
spectra of holo-ALAS were observed at physiological pH within the time period used in this
study, indicating that PLP remained covalently bound to the enzyme (Fig. 4.7A). Further, the
spectra of free PLP did not change within the experimental time period and at all examined pH
values (data not shown).

Reaction with ANS
ANS is a fluorescence probe that is commonly used to characterize the exposure of
hydrophobic surfaces in proteins in order to monitor the formation of partially folded molten
globule-like intermediates (24). Upon reaction with hydrophobic clusters, the emission intensity
of ANS intensifies and is shifted toward shorter wavelengths (24). The fluorescence spectra for
the reaction between mALAS2 and ANS are shown in Fig. 4.8, while graphical representation of
the wavelength of emission maxima and emission intensity are shown in Fig. 4.9A and B,
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respectively. In the absence of protein, ANS in the pH range between 7.5-10.5 displays emission
maxima at 534 nm of equal intensity, which are not affected when the temperature changes from

Figure 4.7. Absorbance spectra of mALAS2 and free PLP recorded at various time intervals and
pH values. (A) pH 7.5: ALAS at time intervals of 0 min (purple), 5 min (cyan), 10 min (blue), 15 min
(pink), 20 min (red), and free PLP (orange). (B) pH 3.0, (C) pH 2.0, and (D) pH 1.0. The color code for
the spectra of ALAS at the different time intervals and free PLP in panels (B)-(D) is the same as in panel
(A). For comparison, the spectrum of ALAS collected at pH 7.5 (black) is also shown in panels (B)-(D).
Note that while the spectra of ALAS in acidic pH at 0 min (purple) resembles that of ALAS at pH 7.5
(black) [panels (B)-(D)], with time, at acidic pH, PLP dissociates from ALAS, with the spectra of ALAS
collected at 20 min (red) resembling that of free PLP (orange) [panels (B)-(D)]. No time-dependent
changes were detected in the spectra of free PLP at any pH value (data not shown).

20 to 37 ºC. However, upon reacting with mALAS2, the fluorescence emission of ANS
intensifies and the maximum is shifted toward shorter wavelengths (Fig. 4.9). The reactivity
between ANS and mALAS2 increases as the alkalinity and temperature are increased, implying
that the hydrophobic clusters of mALAS2 become more exposed to the solvent as a result of
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disruption in the rigidity of the tertiary structure (Figs. 4.8 and 4.9). In the acidic pH range (pH
1-3), when ANS reacts with mALAS2, the shift in the emission maximum toward shorter
wavelengths is comparable to that observed under alkaline conditions; however, the emission
intensity of ANS is significantly more pronounced (Figs. 4.8 and 4.9). This finding indicates
potential differences in the exposure of hydrophobic clusters in acidic and alkaline solution or
presence of some internal quenchers at alkaline pH.

Figure 4.8. Fluorescence spectra for the reaction between ANS and mALAS2. (A) Spectra in pH
range 1-3, and (B) pH range 7.5-10.5. Solid lines represent spectra collected at 20 °C, and dashed lines at
37 °C. The colors are: ANS-mALAS2 complex at pH 1 (pink), pH 2 (purple), pH 3 (grey), pH 7.5 (black),
pH 8.5 (red), pH 9.5 (blue), pH 10.5 (cyan); free ANS is shown in orange.

Figure 4.9. Reaction between ANS and mALAS2 at different pH values at 20 or 37 °C. (A)
Wavelength of emission maxima. (B) Fluorescence emission intensity. The colors correspond to: free
ANS at 20 °C (black), free ANS at 37 °C (gray), ANS in the presence of mALAS2 at 20 °C (blue), and
ANS in the presence of mALAS2 at 37 °C (pink).
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Acrylamide quenching of intrinsic protein fluorescence
Acrylamide quenching studies were performed to characterize how changes in pH and
temperature affect the orientation of tryptophans in mALAS2. The data fitted to the SternVolmer equation are presented in Fig. 4.10, whereas the calculated dynamic quenching constants
are in Table 4.1. At physiological pH, as the temperature changes from 20 to 37 ºC, the dynamic
quenching constant, Ksv, decreases from 8 to 5.1 M-1. This could imply that as the temperature
increases, the protein becomes more dynamic, causing the repositioning of some tryptophans in
an environment that is less accessible to the quencher. In contrast, at pH 1.0 and pH 9.5, as the
temperature increases to 37 ºC, the Ksv values remain identical to those observed at 20 ºC.
However, the Ksv values obtained at pH 1.0 and pH 9.5 are different, indicating subtle differences
in the accessibility of tryptophans under acidic and alkaline conditions.

Figure 4.10. Acrylamide quenching of intrinsic fluorescence of mALAS2. (A) pH 1.0 and 20 °C, (B)
pH 7.5 and 20 °C, (C) pH 9.5 and 20 °C, (D) pH 1 and 37 °C, (E) pH 7.5 and 37 °C, (F) pH 9.5 and 37
°C.
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Table 4.1
Dynamic quenching constants at different pH and
temperature values
pH
Ksv at 20 ºC
Ksv at 37 ºC
M-1
M-1
1.0
7.2 ± 0.1
6.7 ± 0.3
7.5
7.9 ± 0.2
5.1 ± 0.2
9.5
5.6 ± 0.1
5.7 ± 0.3

Dynamic light scattering
Dynamic light scattering was used to examine the propensity of ALAS to self-associate
into higher oligomeric species at different pH values. The greatest propensity for self-association
into higher oligomers was observed at pH 3.0, although a significant heterogeneous oligomeric
population was observed at pH 2.0, and to a lesser extent at pH 1.0, where the hydrodynamic
radius of the most populous species is over 2-fold greater than at physiological pH (Fig. 4.11).
Since in the pH range 6.5-3.2, mALAS2 precipitates out of solution, forming visibly insoluble
aggregates (data not shown), the extent of protein association into higher oligomers depends on
the proximity of the buffer pH to the lower limit of solubility (~pH 3.1). There was no significant
protein association at either pH 7.5 or 9.5 (Fig. 4.11), indicating that at these pH values,
mALAS2 is predominantly a dimer. Interestingly, even at 25 °C, the hydrodynamic radius at pH
9.5 is increased by 12 % when compared to that at pH 7.5. This observation is in agreement with
the CD and ANS data, which showed that structural perturbations are associated with increased
alkalinity.

Is catalysis possible under conditions in which ALAS, devoid of ligands, lacks a rigid
tertiary structure?
To assess if the enzyme retains catalytic activity under conditions in which its structural
integrity is compromised, a colorimetric assay was used to determine the mALAS2-catalyzed
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formation of ALA at different acidic and alkaline pH values. No activity was detected in the
acidic range, while the enzyme remains active in the alkaline pH range up to pH 9.5 (Table 4.2).
This indicates that, although the reaction velocity is about 10-fold lower than at physiological
pH, mALAS2 is active at 9.5 and 37 °C, conditions under which the enzyme adopts, in the
absence of substrates, the molten globule state.

Figure 4.11. Size distribution of mALAS2 at pH values of (A) pH 9.5, (B) pH 7.5, (C) pH 3.0, (D) pH
2.0, and (E) pH 1.0. All experiments were performed using 1 mg/ml protein and at 25 °C.
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Table 4.2
Velocities for the mALAS2-catalyzed formation of
ALA at different pH values
pH
V
(nmol·mg-1·min-1)
10.3
N.A.a
9.5
0.14
8.5
1.10
7.5
1.10
3.0
N.A.a
2.0
N.A.a
1.0
N.A.a
a
N.A., no measurable activity

Comparison of the steady-state kinetic parameters of the alkaline molten globule, as
described for the ALAS state at pH 9.5/37 °C, with those of natively folded ALAS (pH 7.5/37
°C) indicated a 40-fold decrease and a 6-fold increase in the kcat and

values, respectively

(Table 4.3). However, the most drastic reduction was in the specificity constant for succinylCoA,
⁄

⁄

, which was 250-fold lower at pH 9.5 than at pH 7.5 (Table 4.3). The

and

values could not be determined accurately at alkaline conditions because the pH

changed at concentrations of glycine greater than 200 mM.

Table 4.3
Steady-state kinetic parameters of mALAS2 determined at 37 °C and
pH 7.5 or pH 9.5
pH
⁄
-1
(min-1)
(µM)
(min .µM-1)
7.5
2.80 ± 0.10
16 ± 4
175 x 10-3 ± 50 x 10-3
9.5
0.07 ± 0.01
103 ± 32
0.68 x 10-3 ± 0.2 x 10-3
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Is ligand binding to ALAS coupled to its folding in the alkaline molten globule?
To assess whether ligand binding stabilizes the tertiary structure of ALAS, CD spectra in
the near-UV range were collected, at pH 9.5 and 37 °C, in the presence and absence of ALA
(Fig. 4.12). The binding of ALA to the alkaline molten globule state of ALAS increases the
elliptical signal in the near-UV range, implying that ALA binding to ALAS induces folding by
reducing structural fluctuations. A similar substrate-induced stabilization of the tertiary structure
is probably necessary for catalysis. Of relevance, the observed increase in ellipticity results from
stabilization of the tertiary structure, rather than from unbound ALA, since the elliptical signal of
ALA in the absence of enzyme in the near-UV region is near baseline (data not shown). Further,
it was not possible to perform the experiments in the presence of substrates, because succinylCoA has an absorbance maximum at ~260 nm, and at concentrations greater than 100 µM (i.e.,
concentration greater than the Km value at pH 9.5) interferes with the acquisition of the CD data.

Figure 4.12. Binding of ALA to the alkaline molten globule state of ALAS restricts fluctuations in
the tertiary structure. Near-UV CD spectra were collected at 37 °C with the reactants in 50 mM
AMPSO, pH 9.5. Dashed and solid lines correspond to mALAS2 in the absence and presence of ALA,
respectively.
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Discussion
The integrity of the secondary structure of mALAS2 is rather resilient to changes in pH
in the alkaline range. In contrast, the secondary structure becomes disrupted at pH 2.0 where the
enzyme exists as a stable, partially folded intermediate. Since at pH 2.0, mALAS2 is positively
charged due to protonation of its aspartates and glutamates side groups, we hypothesize that the
partial unfolding of the secondary structure results from increased repulsion amongst the
positively charged groups. One would therefore expect greater disruption as the pH is further
decreased; however, rather than becoming less structured, the secondary structure of mALAS2 at
pH 1.0 is restored to nearly native levels (Fig.4.2).
ALAS is by no means the only protein whose secondary structure content becomes
restored under extreme acidic conditions. In fact, Goto et al. were the first to describe the
phenomenon of acid-induced refolding for three different proteins: cytochrome c, apomyoglobin,
and β-lactamase (25). The authors showed that the aforementioned proteins, which exist in fully
unfolded forms at pH 2.0, restore their secondary structure content to nearly native levels as the
pH is further decreased by increasing the concentration of hydrochloric acid (25). The refolding
resulted from the ability of negatively charged chloride ions to minimize repulsion among the
positively charged groups of the protein (25, 26). We also propose that the refolding of the
secondary structure of mALAS2 at extremely low pH results from the ability of the increased
concentration of chloride ions (which are present in the buffer since the pH was adjusted with
hydrochloric acid) to minimize repulsion among positively charged groups. This phenomenon of
acid-induced (25, 26) or anion-induced (27) refolding of acid-unfolded state was also described
earlier for several proteins, such as β-lactamase (28), apomyoglobin (29), cytochrome c (30, 31),
various heme proteins (32), Staphylococcal nuclease (27, 33), ribulosebisphosphate carboxylase
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(Rubisco) from Rhodospirillum rubrum (34), human serum albumin (35), α-chymotrypsinogen
(36), rabbit muscle pyruvate kinase (37), jack bean urease (38), and many other proteins (39, 40).
Under specific acidic (pH 1.0 and pH 3.0) and alkaline (pH 9.5 / 37 °C and pH 10.5)
conditions, mALAS2 exists in a molten globule state, where its secondary structure is mainly
preserved, while the rigidity of the tertiary structure is lost. This finding implies an important
role for ionic interactions in stabilizing the tertiary structure, because upon increasing the same
type of electric charges (either positive or negative), tertiary contacts are disrupted. Ultimately,
this disruption leads to loosening of the side chain packing in the protein core and conversion of
mALAS2 into a molten globule state. Interestingly, the acidic and alkaline molten globule states
of mALAS2 are assumed independently of temperature, with the exception that at pH 9.5 the
molten globule state is observed only at 37 °C. Greater structural mobility, which ensues from
increases in temperature, is probably necessary for the conversion of mALAS2 into the molten
globule state at pH 9.5.
ANS-mALAS2 binding experiments further corroborate that the enzyme populates the
molten globule state under the aforementioned conditions, as inferred from the observation that
the reactivity of the enzyme with ANS is more pronounced in the alkaline molten globule state
than in the native state (pH 7.5). These findings strongly imply greater exposure of the
hydrophobic clusters of mALAS2 in the alkaline solvent due to disruption of the tertiary
structure.
Interestingly, in the acidic pH range, the fluorescence emission intensity of ANS upon
reacting with mALAS2 is significantly more prominent than that observed in the alkaline pH
range (Fig. 4.9). Since at acidic pH there is a greater propensity for self-association, due to the
presence of partially folded intermediates, and thus heterogeneity in ALAS oligomeric species,
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we propose that the increase in fluorescence emission intensity observed at acidic pH results
from ANS interaction with the hydrophobic surfaces of partially folded intermediates and with
those of higher oligomeric species. The fluorescence emission intensity of ANS has been
reported to increase upon interaction with self-associating proteins forming higher oligomers
(41-43).
Quenching of the protein intrinsic fluorescence with acrylamide indicates that the
tryptophans of mALAS2 at pH 1.0 and pH 9.5 have different accessibility to the quencher, as
inferred from their respective Ksv values. This finding implies that the acidic and alkaline molten
globule states of mALAS2 differ subtly, as also suggested by the ANS experiments. At
physiological pH, changing the temperature from 20 to 37 ºC proceeds with a decrease in the
dynamic quenching constant. We hypothesize that an increase in temperature results in greater
mobility of the conformational ensemble of mALAS2, which in turn reduces the accessibility of
tryptophans to the quencher.
In the acidic pH range, the CD signal resulting from the positioning of the internal
aldimine within the chiral active site environment of mALAS2 is lost (Fig. 4.6). The
disappearance of the CD signal results from the dissociation of PLP from the active site, and this
process, as validated by absorbance spectroscopy, occurs in a time-dependent manner (Fig. 4.7).
Our results are in good agreement with those of NMR studies of the reaction between PLP and
free lysine, which led Chan-Huot et al. to conclude that, at pH values below 4, PLP no longer
forms a Schiff base with lysine, but rather exists as a free hydrate (44). Moreover, timedependent dissociation of PLP has been reported for the guanidine deuterochloride denaturation
of aspartate aminotransferase (45).
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Increasing alkalinity causes the 330 nm dichroic band to intensify and the 420 nm band to
weaken. These findings indicate that at pH values of 8.5 or higher, the orientation of the internal
aldimine is different from that observed under physiological conditions, at which the
corresponding 420 nm band predominates. Importantly, the chiral environment of the internal
aldimine is modified in favor of the species with the 330 nm dichroic band at approximately the
same pH value at which mALAS2 becomes less structured. If the alteration in the chirality of the
internal aldimine stems from ionization of group(s) important for the positioning of the cofactor
or through water molecules that modify previously established interactions between PLP and
active site groups, then a shift to a less structured conformational subset probably assists the
tautomeric interconversion by making the active site more accessible to the solvent. However,
we cannot exclude the possibility that the alteration in the chiral environment of the internal
aldimine results solely from conformational rearrangements. It is interesting to note that upon
stabilization of a particular conformational subset, shift in the tautomeric equilibrium of the
internal aldimine toward the 340 nm absorbance species was reported for tyrosine phenol lyase,
when this fold type I PLP-dependent enzyme was encapsulated in wet nanoporous silica gel (46).
While the enzyme does not retain any measurable activity in the acidic pH range under
the assay conditions, it remains active in the alkaline pH range up to pH 9.5. The most surprising
finding is that mALAS2 is catalytically active even in the molten globule state (pH 9.5 and 37
ºC), with the holoenzyme as a highly dynamic ensemble of interconverting conformations.
However, the catalytic activity of mALAS2 at pH 9.5 and 37 ºC is severely compromised, with
40- and 250-fold reductions in the kcat and

⁄

values, respectively, in relation to those

determined at physiological pH (Table 4.3), implying that the ability of the enzyme to effectively
convert its substrates into products is impaired. Clearly, ligand binding to ALAS partly restricts
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the conformational fluctuations observed in the alkaline molten globule state of the holoenzyme
(Fig. 4.12). The ligand-induced conformational stabilization is likely to determine the structural
reorganization and transition to a conformation amenable for catalysis. However, even with the
ligand-dependent conformational stabilization, the catalytic activity of ALAS remains hindered,
suggesting an energetic penalty associated with the structural reorganization to the catalytically
competent conformation that contributes, at least partly, in lowering the catalytic efficiency of
the enzyme. Since no activity was detected in the acidic pH range and at pH 10.5, where ALAS
also assumes a molten globule state, the abolished activity may not entirely stem from structural
disorder, but rather at acidic pH, it results from dissociation of PLP from the active site, and at
pH 10.5, from deprotonation of the catalytically important Lys313, which acts as a base and acid
catalyst during the reaction cycle (47).
In this study we have shown that ALAS exists as an intrinsically disordered molten
globule under specific acidic and alkaline conditions. Yet the question remains whether under
physiologically relevant conditions, apart during the folding process, ALAS ever exists in an
intrinsically disordered state. One way to address this question is to examine if any of the XLSA
mutations affect the folding pathway of ALAS, where the variant fails to fold to the native state,
and populates a less structured state. Of particular interest are XLSA mutations in patients
responsive to pyridoxine treatment (4). About two-thirds of XLSA patients respond to treatment
with pyridoxine (which, like PLP, is a B6 vitamer). While the mechanism through which
pyridoxine restores the catalytic activity of ALAS is not understood (4), the presumption has
been that the mutated enzymes bind PLP less tightly, and given that pyridoxine is enzymatically
converted to PLP, the increased PLP concentration would lead to increased ALAS activity. Since
the binding of ligands has been shown to promote structural disorder-to-order transition in
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certain proteins (48), it would be useful to examine if there are any XLSA mutations where the
binding of PLP to the ALAS variants promotes conversion of the enzyme to a more structured
and catalytically competent conformation.
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Chapter Five
Summary and conclusion

Ever since the purification of ALAS and identification that PLP is utilized as a cofactor,
the central question pertinent to the reaction mechanism was weather the external aldimine
formed between glycine and PLP would be deprotonated or decarboxylated to generate a
carbanion intermediate that can condense with succinyl-CoA (1). Radiolabeling, mutagenic, and
kinetic studies provided evidence in favor of initial deprotonation of the glycine external
aldimine, implying that the subsequent 2-amino-3-ketoadipate intermediate is on the reaction
pathway, and that ALA is generated upon decarboxylation of this intermediate (2-7). However,
direct experimental evidence for the inferred 2-amino-3-ketoadipate intermediate was lacking,
mainly because of the challenges in isolating this intermediate with its carboxyl group intact,
given the rapidity of the enzymatically catalyzed reaction (6). To surmount the challenges
presented by the chemical liability of the 2-amino-3-ketoadipate intermediate, we resorted to
using the pseudo substrate, O-methylglycine, and examined the ALAS-catalyzed reaction. Since
the carboxyl group of O-methylglycine is methylated and protected against decarboxylation,
condensation with succinyl-CoA is only possible through initial deprotonation of the C-α. Using
LC-MS/MS to study the ALAS reaction with O-methylglycine and succinyl-CoA we confirmed
the presence of the methyl ester of the 2-amino-3-ketoacid intermediate, implicating its existence
on the reaction pathway. Consistent with previous reports (2, 3, 6, 7), our results are supportive
of an ALAS-catalyzed reaction that entails initial proton removal from the glycine external
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aldimine. This is further supported by the spectroscopic detection of the quinonoid intermediate
upon reaction of glycine with mALAS2, which interconverts with the external aldimine at a
similar rate, although we have estimated that in the absence of succinyl-CoA, the quinonoid
intermediate is catalyzed by only a small fraction of the enzyme population.
Interestingly, while ALAS is capable of utilizing acyl-CoA substrates other than
succinyl-CoA (8), the enzyme shows strict specificity toward glycine as the only naturally
occurring amino acid substrate (3, 9). In an effort to examine the kinetic basis of this specificity,
we have conducted transient kinetic analyses, and observed that the progress curve of the
reaction between mALAS2 and L-serine is characterized by a lag phase, not detectable during
the reaction with glycine. The presence of a lag phase is commonly observed in hysteretic
enzymes (10), implying that the entry of serine into the tightly packed active site of ALAS
results in a conformational strain. Modeling of the L-serine external aldimine from the closely
related Sphingomonas paucimobilis SPT into the active site of ALAS revealed differences
between the orientations of serine and glycine. In fact, the model implied that the carboxyl group
of L-serine prevents the productive binding of succinyl-CoA due to steric clashes. This
unfavorable orientation of L-serine can in part explain the inability of ALAS to catalyze the
condensation between L-serine and succinyl-CoA, with the reaction proceeding as far as the
formation of the L-serine external aldimine. Moreover, the model predicted potential clashes
between L-serine and T148. When we mutated this amino acid to an alanine, there was no lag
phase in the progress curve for the reaction of the T148A variant and L-serine, consistent with
the role of this threonine in modulating the enzymatic specificity toward the amino acid substrate
(7, 9). Finally, a lag phase was also detected during the ALAS-catalyzed formation of the
external aldimine with ALA, but not the quinonoid intermediate.
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We have recently identified an alternative channel that serves as a potential path of entry
and exit of glycine and ALA to and from the active site of Rhodobacter capsulatus ALAS (11).
The opening and closing of this channel is partly regulated by N85’ from the glycine-rich stretch
of the opposite monomer. Moreover, this asparagine also coordinates the positioning of succinylCoA and the condensation intermediate in the active site, implicating important role for effective
catalysis (12). In order to assess its effects on catalysis, we mutated the analogous asparagine of
mALAS2 to a histidine (N150H), and performed detailed kinetic and equilibrium studies.
Comparisons of the steady-state kinetic parameters with the wild-type enzyme revealed 50 %
decrease in the kcat value of N150H, but without changes in

. Moreover, the binding

affinity toward succinyl-CoA is not perturbed by the N150H mutation, since the Kd value of the
variant is identical with that of wild-type mALAS2. Our data also revealed that the binding of
succinyl-CoA to ALAS is primarily facilitated by the CoA rather than the succinyl-moiety, as
evident from the identical Kd values that were obtained for succinyl-CoA and CoA. Interestingly,
there is a notable difference between the Km and Kd values for succinyl-CoA. For the wild-type
enzyme, the Kd value is about 230-fold greater than the Km value. These findings imply that
does not represent a measure of substrate affinity analogous to the k-1/k1 term which
describes the Kd, but rather it represents a complex kinetic function of all the rate constants in the
pathway.
When the N150H-catalyzed reaction with glycine and succinyl-CoA was examined
during a single turnover using stopped-flow spectroscopy, we detected significant reductions in
the observed pre-steady-state rates for the formation (k1) and decay (k2) of the quinonoid
intermediate II, suggesting that N150 is important for effective catalysis of this intermediate,
possibly by promoting attainment of a catalytically optimal orientation between the condensation
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intermediate and reactive centers. Moreover, when the formation of the quinonoid intermediate
for the N150H catalyzed reaction between glycine and succinyl-CoA was examined during
multiple turnovers, prolonged decay of the quinonoid intermediate into the steady state was
observed, in contrast to the steep decay of this intermediate for the wild-type reaction. This
prolonged decay resulted from accelerated transformation of the product, ALA, into the
quinonoid intermediate during the reverse N150H-reaction, catalyzed at a rate that is increased
by 59 % than the wild-type reaction. Importantly, our results imply that N150 is essential in
establishing catalytic balance between the forward and reverse reactions of mALAS2 by favoring
formation of ALA over its non-productive transformation into the quinonoid intermediate. We
arrived to this conclusion based on the differences that were detected in the rates of quinonoid
intermediate formation during the forward (i.e., with glycine and succinyl-CoA) and reverse (i.e.,
with ALA) reactions catalyzed by the N150H and wild-type enzymes. In fact, relative to their
respective forward reaction rates of quinonoid catalysis, N150H transforms ALA into the
quinonoid intermediate at a rate that is 1.7-fold higher, while for wild-type ALAS, this reverse
reaction with ALA is 6.3-fold lower.
Since even subtle disturbances in the rate of ALA synthesis due to loss-of-function or
gain-of-function mutations in the ALAS2 gene result in X-linked sideroblastic anemia (13) and
X-linked dominant protoporphyria (14), respectively, it is evident that the necessity to evolve
away from hypoactivity and hyperactivity must have been a defining evolutionary pressure in
shaping the active site architecture of ALAS. Our results suggest that the active site environment
of ALAS has also been optimized by evolution to minimize non-productive transformation of
ALA and to establish a catalytic balance between the forward and reverse reactions. This
catalytic balance was at least partly accomplished by the selection of the invariant N150, which
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endowed ALAS with improved catalytic specificity toward the reaction with glycine and
succinyl-CoA, and therefore, ensured that ALA is predominantly utilized for heme biosynthesis.
Contrary to the assumption that catalysis is incompatible with structural disorder, certain
enzymes have been shown to retain catalytic activity even when, devoid of ligands, they populate
an intrinsically disordered molten globule state (15-18). In the molten globule state, proteins
preserve native-like secondary structure content, but due to absence in the close packing of their
side chains, the rigidity of the tertiary structure is disrupted (19). In this study, we have examined
the effects of pH (1-3 and 7.5-10.5) and temperature (20 and 37 ºC) on the structural integrity of
mALAS2 with the aim of characterizing whether catalysis is compatible with structural disorder.
The secondary structure, as deduced from far-UV CD, was mostly resilient to pH and
temperature changes. Partial unfolding was observed at pH 2.0, but further decreasing pH
resulted in acid-induced refolding of the secondary structure to nearly native levels. This acidinduced refolding resulted from minimization of the repulsion among positively charged groups
due to association with negative chloride ions. The tertiary structure rigidity, monitored by nearUV CD, was lost under acidic and specific alkaline conditions (pH 10.5 and pH 9.5/37 °C),
where ALAS populates the molten globule state. As the enzyme became less structured with
increased alkalinity, the chiral environment of the internal aldimine was also modified, with a
shift from a 420 nm to 330 nm dichroic band. Under acidic conditions, the PLP cofactor
dissociated from ALAS in a time-dependent manner as confirmed by absorbance spectroscopy.
Reaction with 8-anilino-1-naphtalenesulfonic acid corroborated increased exposure of
hydrophobic clusters in the alkaline and acidic molten globules, although the reaction was more
pronounced with the latter, probably due to greater propensity for self-association into higher
oligomers. Importantly, we have shown that the alkaline molten globule state (pH 9.5/37 °C) is
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catalytically active, although the catalytic activity is severely compromised, with 40-fold and
250-fold reductions of kcat and kcat/

, respectively, in comparison to those determined at

physiological values. The binding of ALA to the alkaline molten globule state minimized
conformational fluctuations, which is probably necessary for the enzyme to assume a
catalytically competent conformation. Therefore, through effective coupling between the binding
of ligands and folding, ALAS retains catalytic activity even under conditions where the
holoenzyme populates the alkaline molten globule state.
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Appendix 1
Synthesis of 5-amino-6-methoxy-4,6-dioxohexanoic acid
O
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4-(Benzyloxy)-4-oxobutanoic acid (2). To an ice-cooled solution of benzyl alcohol (3.10 ml,
30.0 mmol) in dichloromethane (Volume: 75 ml) was added triethylamine (6.25 ml, 44.8 mmol)
and 4-dimethylaminopyridine (DMAP) (0.15 g, 1.228 mmol) followed by the dropwise addition
of succinic anhydride (2.5 g, 24.98 mmol). The reaction mixture was stirred at room temperature
overnight and washed with 1N HCl (2×30 mL) and brine (30 mL). The organic layer was dried
on sodium sulfate and concentrated in vacuo. On standing, the oily product solidified. The solid
was shown to contain an impurity (likely from triethylamine), and thus, the solid was washed
with water and hexane, and, lastly, dried under vacuum to give a white solid (2.76 g isolated).
6-Benzyl 1-methyl 3-oxohexanedioate (3). A dry flask was charged with 4-(benzyloxy)-4oxobutanoic acid (1g, 4.80 mmol) and anhydrous THF (Volume: 10.67 ml) under an atmosphere
of nitrogen. To the solution was then added 1,1'-carbonyldiimidazole (CDI) (0.935 g, 5.76
mmol) and the resulting mixture was stirred for 1 h at room temperature.
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At this time,

magnesium chloride (0.457 g, 4.80 mmol) and potassium 3-methoxy-3-oxopropanoate (0.750 g,
4.80 mmol) were both added at once. The solution was then stirred overnight at 35 °C (oil bath).
The resulting white slurry was filtered through celite, rinsed with THF, and the filtrate was
concentrated in vacuo. The residue was then diluted with ethyl acetate (EtOAc) and washed
sequentially with 1M HCl, saturated NaHCO3, and brine. The organic fraction was dried over
Na2SO4. 1H-NMR and LC/MS showed mostly the expected product with a minor impurity. The
material was used without further purification.

1

H-NMR (CDCl3): 7.35 (5H, m), 5.12 (2H, s),

3.73 (3H, s), 3.50 (2H, s), 2.88 (2H, t, J = 6.5 Hz), 2.68 (2H, t, J = 6.5 Hz). LC/MS: 287
(M+23).
6-Benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (4). A flask was charged with 6benzyl 1-methyl 3-oxohexanedioate (958 mg, 3.63 mmol) in acetic acid (14 ml) and cooled in an
ice water bath (the solution solidified initially, it was then allowed to warm to the point of
stirring). Once cooled, a solution of sodium nitrite (375 mg, 5.44 mmol) in water (7 ml) was
added dropwise (slowly over ~10 min, keeping the temperature below 10 °C). The solution was
then allowed to slowly warm to room temperature in the ice water bath. Upon completion (by
LC/MS), the solution was diluted with EtOAc and washed twice with water and twice with
saturated NaHCO3. The organic portion was dried over Na2SO4 and concentrated in vacuo to
give 6-benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (986 mg, 3.36 mmol, 93% yield).
1

H-NMR showed full conversion with trace impurities. The material was used without further

purification. 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.28 (m, 5H), 5.13 (s, 2H), 3.90 (s, 2H), 3.16
(t, J = 6.7 Hz, 2H), 2.72 (t, J = 6.8 Hz, 2H). LC/MS: 316.0 (M+23).
6-benzyl 1-methyl 2-((tert-butoxycarbonyl)amino)-3-oxohexanedioate (5). A round bottom
flask was charged with 6-benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (0.5 g, 1.705
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mmol) in acetic acid (20 ml) and cooled to 0 °C. To this solution was then added BOC2O (3.72
g, 17.05 mmol), followed by the portion-wise addition of zinc dust (1.115 g, 17.05 mmol). The
reaction mixture was then warmed to 50 °C in an oil bath. LC/MS after 1 h showed complete
consumption of the starting material and the solution was cooled to room temperature. Water
was then added and the mixture was filtered through celite, washing with dichloromethane. The
organic portion was then washed with saturated NaHCO3 and dried over Na2SO4. The residue
was purified on a 50 g SiO2 column using a hexane/EtOAc gradient (15% to 30%). The clean
fractions were combined to give 149 mg (23%) of the expected product (additional product was
present in mixed fractions). 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.28 (m, 5H), 5.72 (d, J = 6.9
Hz, 1H), 5.12 (s, 1H), 5.10 (s, 2H), 3.80 (s, 3H), 2.88 (t, J = 6.5 Hz, 1H), 2.74 – 2.64 (m, 3H),
1.44 (s, 9H). LCMS: 402.1 (M+23).
5-Amino-6-methoxy-4,6-dioxohexanoic acid hydrochloride (6). A vial was charged with 6benzyl 1-methyl 2-((tert-butoxycarbonyl)amino)-3-oxohexanedioate (75 mg, 0.198 mmol) and
CH2Cl2 (1.5 ml). To this solution was then added TFA (0.5 ml) and the mixture was stirred until
deprotection was complete by LCMS (~30 min). The reaction was then concentrated in vacuo.
1

H NMR and LC/MS showed only minor impurities so the material was carried forth in the next

step. A round bottom flask was charged with 5% Pd/C (30 mg, 0.014 mmol) under an
atmosphere of nitrogen. To this was then added methanol (3 ml) and 6-benzyl 1-methyl 2amino-3-oxohexanedioate (55.3 mg, 0.198 mmol). A hydrogen-filled balloon was then affixed
to the reaction vessel and the flask was evacuated then purged with hydrogen three times. The
mixture was then vigorously stirred at room temperature. LC/MS after 1 h showed complete
cleavage of the benzyl ester. The mixture was filtered through celite, washing with additional
methanol. Concentration gave 73 mg of crude product. To this residue was then added 4N
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HCl/dioxane and diethylether. Partial concentration in vacuo resulted in the formation of a white
solid which was shown to be the clean hydrochloride salt. Filtration and concentration in vacuo
gave 18 mg (40%) of 6. 1H NMR (500 MHz, D2O) δ 3.95 (s, 3H), 3.39 – 3.25 (m, 1H), 3.11 –
2.97 (m, 1H), 2.75 (m, 2H). The methine peak is obscured by the D2O peak, but it appears at
5.38 (s, 1H) in DMSO-D6 (though DMSO obscures the methylene peaks). LC/MS: 190.0 (M+1).
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